Therapeutic Potential of Natural AntioxidantsView this Special Issue
Review Article | Open Access
Joanna Kocot, Małgorzata Kiełczykowska, Dorota Luchowska-Kocot, Jacek Kurzepa, Irena Musik, "Antioxidant Potential of Propolis, Bee Pollen, and Royal Jelly: Possible Medical Application", Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 7074209, 29 pages, 2018. https://doi.org/10.1155/2018/7074209
Antioxidant Potential of Propolis, Bee Pollen, and Royal Jelly: Possible Medical Application
Honeybees products comprise of numerous substances, including propolis, bee pollen, and royal jelly, which have long been known for their medicinal and health-promoting properties. Their wide biological effects have been known and used since antiquity. Bee products are considered to be a potential source of natural antioxidants such as flavonoids, phenolic acids, or terpenoids. Nowadays, the still growing concern in natural substances capable of counteracting the effects of oxidative stress underlying the pathogenesis of numerous diseases, such as neurodegenerative disorders, cancer, diabetes, and atherosclerosis, as well as negative effects of different harmful factors and drugs, is being observed. Having regarded the importance of acquiring drugs from natural sources, this review is aimed at updating the current state of knowledge of antioxidant capacity of selected bee products, namely, propolis, bee pollen, and royal jelly, and of their potential antioxidant-related therapeutic applications. Moreover, the particular attention has been attributed to the understanding of the mechanisms underlying antioxidant properties of bee products. The influence of bee species, plant origin, geographic location, and seasonality as well as type of extraction solutions on the composition of bee products extracts were also discussed.
Bee products like propolis, bee wax, pollen, royal jelly, as well as honey had been known and used even in antiquity and the Middle Ages. For example, in ancient China, bee pollen was applied as a cosmetic agent contributing to skin whitening. At present, these substances are applied in a branch of complementary and alternative medicine—apitherapy. Moreover, the interest in their use as agents in the cure of cancers, neurodegenerative, cardiovascular, and gastrointestinal tract diseases as well as the treatment of wounds and burns has still been growing [1–10].
Bee products are considered to be a potential source of natural antioxidants capable of counteracting the effects of oxidative stress underlying the pathogenesis of numerous diseases.
In general, the compounds possessing phenolic character, which belong to substances expressing ability to scavenge free radicals, are mainly responsible for bee products’ antioxidant capacity [11–14]. They comprise of two main groups of compounds—flavonoids and phenolic acids .
Flavonoids are plant derivatives of polyphenolic structure comprising several subgroups like flavones, flavonols, flavanones flavanonols, flavanols (catechins), anthocyanins, and chalcones, as well as isoflavones and neoflavonoids. The best known subgroups are the compounds containing benzo-γ-pyrone skeleton. Flavonoids often occur in the form of glycosides, in which they play a role of aglycones connected by a glycosidic bond with a carbohydrate group [15–17]. The presence of phenol groups in the molecules of flavonoids imparts them the antiradical activity all the more because the radicals formed during scavenging are resonance stabilized . The examples of flavonoids and their glycosides found in bee products are presented in Figure 1.
The phenolic acids are compounds possessing carboxylic and phenol groups. Recently, a growing concern in their possible application for human health protection has been observed, considering their antioxidant activities including the prevention of oxidation processes and generation of oxygen species as well as chelating prooxidative metals . The examples of phenolic acids and their derivatives found in bee products are presented in Figure 2.
To compounds without phenolic character being responsible for the antioxidant capacity of propolis (especially Brazilian one) belong amyrins [19, 20]. α- and β-amyrins belong to triterpenoids of plant origin. They have been reported to exhibit numerous beneficial properties including antiapoptotic, antioxidant, anti-inflammatory, and antifibrotic as well as gastro- and hepatoprotective effects. Studies have revealed the possible application of β-amyrin in Parkinson’s disease therapy [21, 22]. The examples of amyrins found in bee propolis are presented in Figure 3.
Considering the antioxidant activity of royal jelly hydroxy dicarboxylic fatty acids with 8–12 carbon atoms in the chain and their derivatives is worth mentioning. The major fatty acid is 10-hydroxydecanoic acid (10-HDA) whose presence has not been reported in any other natural raw material or even in any other product of apiculture . Other carboxylic acids included in RJ are 10-hydroxy-2-decenoic acid (10H2DA) and sebacic acid (SA)  (Figure 4).
In scientific research, propolis and bee pollen extracts are used instead of the raw substance due to the fact that they contain higher amounts of bioactive components . However, the application of solvents of different polarities affects the composition of the obtained extracts as the components of bee products possess diverse structures, and while hydrophilic ones are better soluble in polar solvents like alcohols, those with hydrophobic properties exhibit greater affinity to nonpolar solvents like hydrocarbons. The properties of the extract depend strongly not only on the solvent used but also on extraction conditions, that is, time and temperature as well [13, 25].
Having regarded the importance of acquiring drugs from natural sources, this review is aimed at updating the current state of the knowledge of antioxidant capacity of the selected bee products, namely, propolis, bee pollen, and royal jelly, and of their possible medical applications as natural substances capable of counteracting the effects of oxidative stress underlying pathogenesis of numerous diseases, such as neurodegenerative disorders, cardiovascular diseases, diabetes, and cancer, as well as negative effects of different harmful factors and drugs. Moreover, particular attention has been attributed to the understanding of the mechanisms underlying possible antioxidant properties of bee products. The influence of bee species, plant origin, geographic location, and seasonality, as well as type of extraction solutions on the composition of bee products extracts were all discussed.
2. Propolis: “Bee Glue”
Propolis, generally known as the “bee glue,” is a resinous mixture that honey bees produce by mixing their saliva containing certain enzymes and beeswax with exudate gathered mainly from leaf and flower buds, stems, and bark cracks of numerous species of trees. The word propolis is derived from two Greek words pro and polis, which mean “defense” and “city” or “community,” respectively. Bees use it mainly as a sealant and a disinfecting material. Propolis is used for sealing holes and cracks, smoothing the inner surface, and retaining internal temperature of the beehive as well as for preventing weathering (e.g., it is used for decreasing the size of the outlet opening during periods of cold weather) and invasion of predators [3, 26]. Due to its antimicrobial activity, it also contributes to an aseptic internal environment and is used to cover (“mummify”— to prevent decay) the body of dead pests that have invaded the hives (e.g., shrews and mice), which are too big to be removed outside .
2.1. Composition of Propolis
Raw propolis is typically composed of 50–60% of resins and balms (including phenolic compounds), 30–40% of waxes and fatty acids, 5–10% of essential oils, 5% of pollen, and about 5% of other substances including amino acids, micronutrients, and vitamins (thiamin, riboflavin, pyridoxine, C, and E) [20, 27]. According to the literature data, more than 300 compounds belonging to polyphenols, terpenoids, steroids, sugars, amino acids, and others have been identified in propolis [3, 28].
Propolis from the temperate zone all over the world (Europe, nontropic regions of Asia, North America, and continental Australia) is classified as the poplar type propolis since it originates mainly from the bud exudates of Populus spp., most often P. nigra L. The main biologically active components of this type of propolis are flavonoids (flavones and flavanones), phenolic acids (cinnamic acid), and their esters [27–29]. Birch propolis, found in Russia, originates from Betula verrucosa Ehrh. and similarly contains flavones and flavonols (but not the same as in poplar propolis) . Mediterranean propolis is characteristic of subtropic regions like Greece, Greek islands, Sicily, Malta, Cyprus, Croatia, and Algeria. It originates mainly from the resin of Cupressus sempervirens (commonly known as the Mediterranean or Italian cypress) and is characterized by relatively high amounts of diterpenes [28, 29]. In tropical zones, in turn, several types of propolis derived from many different sources have been identified. For example, in Brazil, there are 13 different types of propolis including green, red, and brown ones, whose main sources are Baccharis dracunculifolia, Dalbergia ecastaphyllum , and Hyptis divaricata, respectively. The most popular is the green one, which owes its color to the chlorophyll occurring in young tissues and nonexpanded leaves of B. dracunculifolia and collected by the bees . This type of propolis is rich in derivatives of phenylpropanoids (e.g., artepillin C) and diterpenes, whereas flavonoids occur in small amounts . The red propolis is characterized by the presence of numerous flavonoids (formononetin, liquiritigenin, pinobanksin-3-acetate, pinobanksin, luteolin, rutin, quercetin, pinocembrin, daidzein, and isoliquiritigenin), which are found in the resinous exudates from the surface of D. ecastaphyllum [30, 32]. This type of propolis is also characteristic of Cuba and Mexico . The brown propolis is mainly produced in northeastern Brazil from H. divaricata . Other examples of tropical propolis include the one originating from resin exuded by the flowers of Clusia sp. found in Cuba and Venezuela—with its main constituents being derivatives of benzophenones—and “Pacific” propolis originating from the tropical tree Macaranga tanarius found on Pacific Ocean tropical islands (Taiwan, Okinawa, and Indonesia), which chemical makers are C-prenylflavanones [29, 33].
2.2. Relationships between the Antioxidant Capacity of Propolis and Its Composition
Antioxidant properties of propolis have been fully investigated and proven with the use of DPPH, ABTS+, FRAP, and ORAC methods [3, 19, 20, 29, 31, 34–38]. In the same in vitro studies, the antioxidant capacity of propolis extracts was found to be similar to that of the synthetic antioxidant butylated hydroxytoluene or ascorbic acid [4, 20]. Importantly, the antioxidant capacity of propolis is dependent on its content, but the studies aiming at finding the distinct relationships between these two parameters are not consistent [3, 35, 36]. In general, according to the literature data, the total phenolic content of propolis extracts ranged from about 30 to 200 mg of gallic acid equivalents (GAE)/g of dry weight, and the flavonoid content ranged from about 30 to 70 mg of quercetin equivalents (QE)/g, whereas DPPH free radical-scavenging activity ranged from about 20 to 190 μg/mL [3, 19, 20, 31, 35, 36, 38]. The phenolic compounds, but the different ones than the flavonoids, are believed to be responsible for the antioxidant activity of Brazilian propolis. According to Zhang et al. , 3,4,5-tricaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid, and artepillin C seem to be responsible for the strong antioxidant activity of Brazilian green propolis. Unlike in the case of Brazilian propolis, the antioxidant activity of poplar propolis appears to be largely influenced by both total polyphenol and total flavonoid contents [3, 34, 38]. The results obtained by Fabris et al.  indicated that European (Italy and Russia) propolis samples had similar polyphenolic composition and consequently similar antioxidant activity, while Brazilian propolis possessed lower polyphenolic amount and thus antioxidant properties. In general, there seems to be a big problem with the standardization of propolis composition—this results from the fact that this is highly dependent on many factors, such as bee species, plant origin, geographic location, temperature variation, and seasonality, as well as storage conditions [3, 19, 20, 27, 31, 36, 40]. Recently, for example, Bonamigo et al. [19, 20] have studied the antioxidant activity of the ethanol extract of Brazilian propolis samples (collected from the same region) depending on bees’ species, Scaptotrigona depilis, Melipona quadrifasciata anthidioides, Plebeiadroryana, and Apis mellifera. The studied samples were shown to differ in composition as well as in both free radical-scavenging activity and ability to inhibit lipid peroxidation. In general, propolis obtained from A. mellifera revealed the highest activity. Calegari et al. , in turn, found that Brazilian propolis samples produced in both March and April showed a difference in color and higher content of total phenolic compounds as well as antioxidant capacity than those produced in May and June, which indicated that the chemical composition of propolis depended on the month of production—this effect can be explained by variations in temperature. The researchers also reported that bees’ colonies, which received food supplementation every three days throughout the year, displayed significantly higher total phenolic and flavonoids content as well as antioxidant capacity than those bereaved of this supplementation .
Moreover, both the chemical composition and biological properties of propolis extracts are highly dependent on the type of solvents used for the extraction [3, 31, 34]. The most commonly used solvent for the extraction of propolis is aqueous ethanol (particularly at concentration of 70–75%), followed by others, such as ethyl ether, water, methanol, hexane, and chloroform. Sun et al.  showed that extraction yields (the ratio of the weight of the dry extract to the weight of the raw extract) of Beijing propolis ranged from 1.8% to 51% and exhibited the tendency to increase along with the enhancement of the ethanol concentration. The total polyphenol and total flavonoid content distinctly varied and ranged from 6.68 to 164.20 mg GAE/g and 4.07 to 282.83 mg of rutin equivalents (RE)/g, respectively, and the highest concentration was observed in 75% ethanol solvents, a little bit lower in 95% and 100% ethanol solvents and the lowest one in water solution. The 75% extract also demonstrated the highest antioxidant capacity measured by DPPH, ABTS, FRAP, oxygen radical absorbance capacity (ORAC), and cell antioxidant activity (CAA) methods. In general, polar solvents allow obtaining better antioxidant properties than the nonpoplar ones. However, considerable differences were observed even in the case of the application of solvents of similar polarity or the same solvent for the extraction of different types of propolis samples , pointing to the possible influence of other parameters as well as the impact of the molecular structure of solvents. Bittencourt et al. , for example, showed that that partition with dichloromethane enhanced the extraction of antioxidant compounds, especially in brown propolis, whereas partition with hexane significantly decreased their amount in green propolis extract (Table 1).
Importantly, despite numerous differences in its composition, propolis extract always possesses antioxidant properties. Even the aqueous extracts of propolis were shown to display antioxidant capacity in cell culture and animal studies [9, 12].
2.3. Antioxidant Effect of Propolis in Human Studies
Most of the studies regarding antioxidant properties of propolis have been performed on cell culture or animals. In the available literature, there are only a few studies investigating the antioxidant effect of propolis in humans.
Mujica et al.  evaluated the effects of the oral administration (twice daily, 15 drops each time, 90 days) of commercially available propolis solution (Beepolis®) on the oxidative status and lipid profile in a human population in Chile. The 90-day propolis supplementation resulted in a 67% decrease in the amount of thiobarbituric acid reactive substances (TBARS; lipid peroxidation derivative products) and 175% increase in reduced glutathione (GSH) level compared to the baseline. Net changes of both studied parameters were significantly higher in propolis supplemented group than those observed in the placebo group. Moreover, an increase in the HDL concentration on the 90th day of propolis supplementation compared to the baseline value was observed. The authors concluded that propolis supplementation appeared to have positive effects on oxidative status and the improvement of HDL and may thus reduce the risk of cardiovascular events.
Jasprica et al. , in turn, investigated the issue of the possible influence of 30-day supplementation with commercially available powdered propolis extract (a total daily dose of flavonoids was 48.75 mg) on antioxidant enzymes such as superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), and a lipid peroxidation marker—malondialdehyde (MDA)—in healthy individuals. In the male group, after 15 days of propolis treatment, a 23.2% decrease in MDA level was observed, whereas after 30 days, a 20.9% increase in SOD activity was found. Interestingly, MDA concentration in the end of treatment was similar to the baseline value. The propolis treatment had no effect on any of the studied parameters in women (). The authors concluded that the effect of propolis was both time and gender dependent and suggested a possibility of existence of only the transitory effect of propolis ingestion on lipid peroxidation.
The effect of Brazilian green propolis supplementation on antioxidant status in patients with type 2 diabetes mellitus (T2DM) was studied by Zhao et al. . The propolis administration (900 mg/day, 18 weeks) was associated with an increase in serum levels of GSH and total polyphenols and reduction in serum carbonyls (protein oxidation markers) as well as lactate dehydrogenase activity. Moreover, the Brazilian green propolis group revealed a decreased TNF-α serum level and significantly increased IL-1β and IL-6 sera levels. However, the propolis treatment did not affect serum glucose, glycosylated hemoglobin, insulin, aldose reductase, or adiponectin. The above results indicate that propolis affects the oxidative stress in type 2 diabetic patients but not the parameters of diabetes.
2.4. Neuroprotective Effects of Propolis
Since mitochondrial damage and oxidative stress are critical events in neurodegeneration, in recent years, it has been suggested that antioxidant properties of the constituents of propolis may contribute to its neuroprotective effects. The effect of water-extracted brown propolis (WEBPs), from two regions of Iran, against cerebral ischemia-induced oxidative injury in a mouse model of stroke was studied by Bazmandegan et al. . Regardless of the region of origin or the used doses, WEBP treatment resulted in a significant restoration of antioxidant enzymes activity and a decrease in both lipid peroxidation and the infarct volume, compared to the control group. Moreover, the treatment was associated with an improvement of neurological deficits measured with the Bederson scale and sensorimotor function measured with sticky removal tape test (Table 2). In another study performed on SH-SY5Y cells , it was found that the pretreatment with Brazilian green propolis reduced the H2O2-induced mitochondria-derived intracellular reactive oxygen species (ROS) generation as well as 8-oxo-2′-deoxyguanosine (8-oxo-dG, the DNA oxidative damage marker) immunofluorescence signal intensity. Propolis was also shown to increase the expression of the critical factors of synapse efficacy, brain-derived neurotrophic factor (BDNF), and activity-regulated cytoskeleton-associated protein (Arc). The obtained outcomes allowed the authors to suggest that propolis displays protective abilities against neurodegenerative damage, related to cognitive impairment caused by Alzheimer’s disease or aging, via its antioxidant action (Table 2). This seems to be consistent with the results obtained by Nanaware et al. , who studied the neuroprotective activity of the macerated ethanolic extract of Indian propolis (MEEP) in rat model of Alzheimer’s disease. MEEP significantly reversed the cognitive impairment of β amyloid-induced rats, which, among other things, was associated with increased antioxidant and decreased MDA levels. In addition, MEEP administration resulted in dose-dependent acetylcholinesterase inhibition, increased brain monoamine level, and improved memory deficits (assessed by increased BDNF level), which suggested that multiple mechanisms might be involved in that neuroprotective effect of propolis (Table 2).
ADMA: asymmetric dimethylarginine; Bax: Bcl-2-related ovarian killer protein; Bcl-2: B-cell lymphoma 2; CAT: catalase; GCLC: glutamate-cysteine ligase catalytic subunit; GCLM: glutamate-cysteine ligase regulatory subunit; Erk 1/2: extracellular signal-regulated kinase ½, FRAP: ferric reducing ability; GPx: glutathione peroxidase; GRx: glutathione reductase; GSH: reduced glutathione; GST: glutathione reductase; HO-1: heme oxygenase-1; JAK 2: Janus kinase 2; MDA: malondialdehyde; NF-κB: nuclear factor kappa B; Nrf2: nuclear factor erythroid 2-related factor 2 (Nrf2); NO: nitric oxide; 8-oxo-2′-deoxyguanosine, P/O: phosphate/oxygen ratio; PON1: paraoxonase; RCR: respiratory control ratio; ROS: reactive oxygen species; STAT3: signal transducer and activator of transcription 3; SOCS3: suppressor of cytokine signaling 3; SOD: superoxide dismutase; TAS: total antioxidant status; TBARS: thiobarbituric acid reactive substances; TOS: total oxidant status; TrxR1: thioredoxin reductase 1; γ-GCS: γ-glutamylcysteine synthetase. ↓: decrease; ↑: increase; ∗∗the effect depended on used dose.
Jin et al.  reported that pinocembrin, one of the most abundant flavonoids in propolis, inhibited 6-hydroxydopamine- (6-OHDA-) induced oxidative stress. Pinocembrin pretreatment induced the translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) to the nucleus in a concentration- and time-dependent manner as well as the subsequent expression of antioxidant response element- (ARE-) mediated antioxidant genes encoding heme oxygenase-1 (HO-1) and γ-glutamylcysteine synthetase (γ-GCS). Nrf2 is known to play a key role in the adaptive response to oxidative and electrophilic stresses as well as maintaining the cellular self-defense. Under physiological condition, Nrf2 is localized in the cytosol and is associated with its negative regulator, Kelch-like ECH-associated protein 1 (Keap1). In response to oxidative/electrophilic stimuli, Nrf2 dissociates from Keap1 and translocates to the nucleus, where it forms a heterodimer with its obligatory partner Maf and then binds to the ARE sequence to activate transcription of genes encoding a large number of antioxidative and electrophile detoxification enzymes including HO-1 and γ-GCS. Pinocembrin also reduced the 6-OHDA-induced cell viability loss and apoptotic rate and partially inhibited the reduction of the Bcl-2 (an apoptosis inhibitor) to Bax (an apoptosis promoter) ratio following 6-OHDA treatment. The treatment of SH-SY5Y cells with the small interfering RNA (siRNA) directed against Nrf2 (Nrf2-siRNA) abolished pinocembrin-induced HO-1 and γ-GCS expression and its protective effects, which suggests that pinocembrin is protective against Parkinson’s disease-related neurotoxin 6-OHDA through Nrf2/ARE pathway (Table 2). De Oliveira et al.  confirmed that pinocembrin exerted mitochondrial and cellular protection by the activation of the extracellular signal-regulated kinase 1/2-nuclear factor erythroid 2-related factor (Erk1/2-Nrf2) signaling pathway, since the inhibition of Erk1/2 or the silencing of Nrf2 abrogated these effects. Erk1/2 protein kinase is an activator of Nrf2. The researchers showed that pinocembrin pretreatment inhibited paraquat-induced lipid peroxidation, protein carbonylation, protein nitration, as well as the oxidation of thiol groups in the membranes of mitochondria of SH-SY5Y cells. Moreover, it activated the translocation of Nrf2 and increased the level of glutamate-cysteine ligase regulatory subunit (GCLM), glutamate-cysteine ligase catalytic subunit (GCLC), GSH, and HO-1. GCLM and GCLC are, respectively, regulatory and catalytic subunits of glutamate cysteine ligase—an enzyme which catalyzes the first and rate-limiting step in the production of the cellular antioxidant GSH. The above effects were blocked or inhibited with the Erk1/2 protein kinase inhibitor PD98059 or Nrf2 siRNA (Table 2).
The neuroprotective effect of another compound abundant in propolis, namely, caffeic acid phenethyl ester (CAPE), against 6-OHDA-induced dopaminergic neuronal loss in rats, was studied by Barros Silva et al. . The cotreatment with CAPE decreased the hydrogen peroxide production in brain striatum homogenates. CAPE was also capable of scavenging ROS by neutralizing the unpaired electrons of DPPH but did not affect 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPOL, a stable nitroxyl antioxidant) in brain-affected areas. Additionally, CAPE protected against 6-OHDA-induced increase of metal levels (Cu, Fe, Mn, and Zn) as well as inhibited mitochondrial permeability transition (MPT), a mediator of neuronal death that triggers cytochrome c release and caspase-3 activation, and this effect was not associated with mitochondrial dysfunction. The authors concluded that basing on the obtained findings and its ability to cross the blood-brain barrier, CAPE could be a promising compound to treat Parkinson’s and other neurodegenerative diseases (Table 2). Mahmoud et al.  demonstrated, in turn, that CAPE protected the brain against hexavalent chromium toxicity by preventing oxidative/nitrosative stress as well as modulating the JAK/STAT signaling pathway in rats. The researchers suggested that oxidative stress along with inflammation caused by Cr(VI) could directly activate the JAK/STAT signaling pathway in the cerebrum of rats, which was confirmed by increased JAK2 mRNA and protein expression and consequently STAT3 mRNA and protein phosphorylation in the cerebrum of Cr(VI)-induced rats. CAPE, in turn, by mitigating oxidative/nitrosative stress, downregulated JAK2/STAT3 signaling, which was also proved by a significant decrease in both JAK2 and STAT3 mRNA and protein levels in CAPE-treated group (Table 2).
2.5. Propolis Role in Mitigation of Chemotherapy Side Effect
In the literature, there are also studies aiming to determine propolis as a potential natural antioxidant to mitigate side effect of chemotherapy. Mitomycin C, cisplatin, and doxorubicin are recognised anticancer drugs used along with radiation or surgery. Unfortunately, their administration may cause diverse side effects, leading to considerable injury of organs and subsequently worsening life conditions. Some aspects of this harmful effect have been attributed to inducing oxidative damage.
Kumari et al.  showed that the hydroethanolic extract of Indian propolis (HEIP) displayed the protective effect against mitomycin C- (MMC-) induced genotoxicity and cytotoxicity which could be, at least partially, mediated via free radical-scavenging activity and inhibitory effect on lipid peroxidation. The potential geno- and cytotoxic effects of MMC in the bone marrow was manifested by a significant increase in the frequency of micronculeated cells and the percentage of apoptotic cells as well as the reduction in polychromatic erythrocyte (PCE) to normochromatic erythrocytes (NCE) ratio (P/N ratio) compared to the control group. However, MMC-induced toxic effects were significantly recovered by pretreatment with HEIP with the optimum dose being 400 mg/kg. In addition, HEIP possessed a considerable DPPH radical-scavenging activity (increasing along with an increase in HEIP concentration), and it exhibited almost such effectiveness as the standard use of ascorbic acid. HEIP was also found to possess the total antioxidant activity (evaluated by method based on the principle of reduction of molybdenum) and exhibited free radical-scavenging activity in FRAP measurement, but in this case, the results were not comparable with those obtained for ascorbic acid. Moreover, HEIP was shown to possess a substantial lipid peroxidation inhibitory activity, but again, it was also not as effective as the reference standard—Trolox (Table 2).
As chemotherapy is known to have fertility-related side effects, in the next study, Kumari et al.  investigated the effect of HEIP on MMC-induced testicular toxicity. The antioxidant effects of HEIP were assessed by measuring antioxidant/oxidant biomarkers in testicular tissue homogenate. MMC treatment resulted in long-term oxidative stress, whereas a single dose preadministration of HEIP was able to attenuate it to a certain degree—a significant decrease in MDA level and an insignificant elevation of GSH level and CAT activity were observed. MMC administration also led to a reduction in testicular function (testis weight, sperm count, sperm motility, and spermatozoa with normal head morphology) in a dose-dependent manner, which was alleviated by HEIP pretreatment (Table 2).
Alyane et al. , in turn, demonstrated that the propolis extract pretreatment substantially attenuated the peroxidative damage in the heart mitochondria following the injection of an acute dose of doxorubicin. Propolis led to a significant reduction in mitochondrial MDA formation and production of superoxide anion, as well as the restoration of respiratory control ratio (RCR—state III respiration/state IV respiration; indicates the tightness of the coupling between respiration and phosphorylation) and phosphate/oxygen ratio (P/O ratio; refers to the amount of ATP produced from the movement of two electrons through a defined electron transport chain. Additionally, a decreased rate and amplitude of mitochondrial swelling were observed (Table 2).
2.6. Propolis’ Ability to Modulate Cardiovascular Disease Markers
The antioxidant properties of propolis have also been suggested to be responsible for its ability to modulate cardiovascular disease markers. Salmas et al. , for example, reported that oxidative alterations occurring in the kidney tissue of chronic hypertensive rats might be prevented via propolis, CAPE, as well as pollen administration. In the kidney tissue of Nω-nitro-L-arginine methyl ester- (L-NAME-) induced hypertensive rats, total antioxidant status (TAS) and paraoxonase (PON1, an important antioxidant preventing the oxidation of low-density lipoproteins) activity, were significantly decreased, whereas total oxidant status (TOS), asymmetric dimethylarginine (ADMA, an endogenous inhibitor of NO synthase), and nuclear factor kappa B (NF-κB, regulated by intracellular redox state) were significantly increased. However, the coadministration of propolis, CAPE, and pollen restored all the disturbed parameters with the propolis samples being the most effective following by pollen and CAPE (Table 2).
Ahmed et al. , in turn, showed that Malaysian propolis (MP) pretreatment ameliorated the negative effects of isoproterenol-induced myocardial infarction in rats. MP exhibited high total antioxidant activity determined by both DPPH and FRAP assays. The isoproterenol administration resulted in significantly elevated lipid peroxides and reduced activities of cellular antioxidant defense enzymes in the myocardium. Moreover, it caused a significant increase in serum cardiac marker enzymes (creatinine kinase-MB, aspartate transaminase, lactate dehydrogenase, and alanine transaminase) and cardiac troponin I levels as well as altered serum lipid profiles. However, the pretreatment of ischemic rats with MP suppressed the above biochemical parameters as well as improved histopathological findings, suggesting the protective effect of MP against ISO-induced ischemia via its direct cytotoxic radical-scavenging activities and possibly via the inhibition of lipid peroxidation (Table 2).
The protective effect of six active compounds of Chinese propolis on H2O2-induced rat cardiomyocytes (H9c2) oxidative injury was also studied . All tested compounds demonstrated significant cytoprotective activities; however CAPE, benzyl caffeate (BZC), and cinnamyl caffeate (CNC) exerted stronger effects than chrysin, pinobanksin, and 3,4-dimethoxycinnamic acid (DMCA). CAPE, BZC, and CHC increased H9c2 cellular antioxidant potential (by decreasing MDA level and increasing SOD and GPx activities), decreased intracellular calcium ion level, and prevented cell apoptosis (Table 2).
The protective effects of ethanol extract of propolis (EEP) against injury induced by oxidized low-density lipoprotein (ox-LDL) in human umbilical vein endothelial cells (HUVECs) were studied by Fang et al. . An atherogenic role of ox-LDL in the progression of atherosclerotic cardiovascular disease is well known. EEP pretreatment ameliorated the ox-LDL-induced oxidative stress by reducing nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation, ROS, and MDA generation as well as elevating antioxidant enzyme activities. In addition, EEP reduced ox-LDL uptake by HUVECs and attenuated ox-LDL-upregulated expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1—a critical molecule responsible for ox-LDL uptake by endothelial cells) both at the mRNA and at protein levels . Moreover, EEP in a dose-dependent manner protected against the decrease in cell viability as well as the increase in lactate dehydrogenase (LDH) release, caspase-3 activation, and apoptosis induced by ox-LDL. The obtained outcomes allowed the authors to conclude that EEP appeared to protect HUVECs from ox-LDL-induced injury via, at least partially, the modulation of LOX-1-mediated oxidative stress.
Tian et al.  proved that the ethanol extract of propolis might protect macrophages from ox-LDL-induced apoptosis and the underlying mechanism at least partially involved its ability to suppress the CD36-mediated ox-LDL intake and the subsequent activation of the endoplasmic reticulum (ER) stress-C/EBP homologous protein (CHOP) pathway; it significantly suppressed the phosphorylation of double-stranded RNA-activated protein kinase-like ER kinase (PERK) and eukaryotic translation initiation factor 2α (eIF2α) as well as the upregulation of glucose regulated protein 78 (GRP78) and the proapoptotic protein CHOP.
El-Awady et al. , in turn, reported that propolis could protect against high glucose-induced vascular endothelial dysfunction via decreasing oxidative stress in isolated rat aorta. Incubation of aortic rings with propolis extract prevented high glucose-induced the impairment of phenylephrine-induced contraction and acetylcholine-induced relaxation. Additionally, a SOD activity and GSH concentration increase as well as a decrease in MDA level were observed (Table 2).
2.7. Propolis as the Protective Agent against Prooxidants’ Toxicity
Antioxidant properties of propolis encouraged the research concerning its application as an agent preventing or alleviating harmful oxidative processes caused by various factors, like trichlorfon, tebuconazole, paracetamol, methylmercury, or UV irradiation.
The beneficial effect of propolis on trichlorfon-induced prooxidant/antioxidant and haematological parameters alterations in carp Cyprinus carpio was stated . Fish were exposed to sublethal concentrations of trichlorfon—a toxic pesticide commonly used in aquaculture to eliminate fish parasites, and propolis was administered simultaneously. The treatment with propolis caused the alleviation of trichlorfon-induced negative alterations in the haematological parameters (red and white blood cell counts, haemoglobin concentration, haematocrit, erythrocyte indices, mean corpuscular volume, mean corpuscular haemoglobin, and mean corpuscular haemoglobin concentration) as well as oxidant markers (MDA, GSH, SOD, CAT, and GPx) in the liver, kidney, and gill samples (Table 2). Ferreira et al. , in turn, showed that bee products, such as propolis, bee pollen, royal jelly, and honey, prevented and/or reversed tissue (brain, liver, and kidney) oxidative damage induced by tebuconazole (an agrochemical fungicide) in fish by increasing the enzymatic activities of SOD, CAT, and glutathione-S-transferase (GST) and decreasing lipid peroxidation (Table 2).
Aksu et al.  investigated the effect of chrysin (CR, a flavonoid occurring in propolis) pretreatment against paracetamol- (PRC-) induced reproductive toxicity in male. The treatment with PRC resulted in reduced sperm motility, antioxidant enzymes activity (SOD, CAT, and GPx), and GSH level, as well as increased dead sperm rate, abnormal sperm cell rate, apoptosis, and MDA level in testicular tissue. CR was found to mitigate the above effects in a dose-dependent manner with the higher dose being more effective. The authors concluded that the possible protection mechanism might be dependent on the antioxidant activity of CR (Table 2). A protective effect of chrysin against methylmercury-induced genotoxicity and oxidative stress was also studied by Manzolli et al. . The cotreatment with chrysin resulted in the restoration of GSH level, and it decreased the formation of comets in leukocytes and hepatocytes (Table 2).
Saito et al. , in turn, demonstrated that Brazilian green propolis and its three main constituents (3,5-di-O-caffeoylquinic acid, 3,4-di-O-caffeoylquinic acid, and chlorogenic acid) increased the HO-1 (heme oxygenase 1) expression and accelerated Nrf2 nuclear translocation after UVA irradiation (the major cause of human skin aging) in human skin fibroblast cells (NB1-RGB).
Propolis has also been suggested to be useful for improving wound healing, which is possibly owed to its antioxidant activity (Table 2). Cao et al.  investigated the protective effects of the ethanol extract of Chinese propolis (EECP) against H2O2-induced oxidative stress in mouse L929 fibroblast cell lines. EECP not only showed significant protective effects against H2O2-stimulated L929 cell death but also reduced the decline of collagen mRNA expression in a significant way. Moreover, EECP induced the expression of antioxidant-related genes, such as HO-1 (encoding heme oxygenase 1), GCLM (encoding glutamate-cysteine ligase regulatory subunit), and GCLC (encoding glutamate-cysteine ligase catalytic subunit) at both mRNA and protein levels in skin fibroblasts (Table 2). Heme oxygenase-1 breaks down heme to carbon monoxide, iron ions, and biliverdin, which is subsequently reduced to bilirubin. Both biliverdin and bilirubin are potent antioxidant agents.
Arabameri et al.  proved that the Iranian propolis could significantly prevent oxidative stress (by alleviating the changes in ferric-reducing antioxidant power, SOD, GPx, and MDA) as well as histopathological changes (the number of ovarian follicles, oocytes, and oocytes diameter) in the ovaries of the neonatal rat following maternal separation stress (infants were separated from their mothers 6 hours per day). All three applied doses exerted positive effect, but the most effective was the dose of 200 mg/kg (Table 2). Mişe Yonar et al. , in turn, investigated the effect of dietary propolis on the number and size of pleopodal egg and oxidative/antioxidant status of freshwater crayfish. Dietary propolis supplementation resulted in a significant decrease in MDA level and CAT and GPx activities as well as a significant increase in SOD activity in hepatopancreas and ovarium. The pleopodal egg number produced per gram of the body weight and total pleopodal egg number significantly increased, whereas the pleopodal egg size significantly decreased following propolis administration. The authors suggested that the reduced activity of CAT and GSH-Px following propolis supplementation could have resulted from the inhibition of superoxide radical formation by the dietary propolis and concluded that propolis improved efficiency in the crayfish and reduced the oxidative stress under controlled hatchery conditions.
Zhang et al.  demonstrated that ethanol extracts of Chinese propolis (EECP) could reduce the intracellular ROS level not only in the H2O2-induced RAW264.7 cells but also in normal RAW264.7 cell (not subjected to any factor). This suggested that propolis could be capable of reducing oxidative stress generated not only under pathological but also under physiological conditions. Similar to Cao et al. , the authors found that EECP in a time- and dose-dependent manner elevated the expression of antioxidant genes such as HO-1, GCLM, and thioredoxin reductase 1 (TrxR1) on both the mRNA and protein levels (Table 2). TrxR, along with NADPH and thioredoxin, is a component of thioredoxin (Trx) system that creates a key antioxidant system as defense against oxidative stress through the disulfide reductase activity, regulating protein dithiol/disulfide balance . Since EECP also increased expressions of phosphorylated Erk and the nucleus translocation of Nrf2, the researchers suggested that propolis might modulate the expression of HO-1, TrxR1, and GCLM via Erk kinase/Nrf2 signal pathway.
2.8. Propolis as a Cosmetics Additive
Propolis was also studied with regard to its potential application in cosmetics. The research revealed that it can act as a sunscreen agent  and could be used as an ingredient of sunscreen cosmetics . Gismondi et al.  studied its usage as an agent-protecting essential oil, added to sunscreens with the aim of preventing cytotoxic and proradical effects of their components, against damage caused by UV radiation. Lavandula angustifolia Miller essential oil samples, pure or added with 30% ethanol propolis solution at a dose of 1%, were subjected to UV radiation. UV exposure depleted the antioxidant activity of essential oil (DPPH, ABTS, and FRAP assay). Propolis supplementation not only prevented this effect but also considerably increased this parameter in both exposed and nonexposed samples. Those promising results were confirmed by experiment performed on highly metastatic murine B16-F10 melanoma cells. The addition of essential oil samples to culture media caused an increase in cellular GPx, SOD, and CAT activity, but in the case of UV-exposed one, this effect was much less or even slight. However, additional propolis prevented the deterioration of oil properties by UV radiation,as in this case, the results obtained in both oil+propolis+UV and oil+propolis treatments were generally not lower that in the case of essential oil alone.
3. Bee Pollen
Bee pollen is produced from plant flower pollen, which is collected by bees and mixed with nectar or the salivary gland secretion of the insects. In such form, it is transported, placed on the hind legs, to hives. Then flightless bees mix it with their saliva and pack into honeycombs, covered with a mixture of wax and honey. Under such conditions, the anaerobic fermentation proceeds with the formation of lactic acid, serving as a preservative. The substance, produced in this way, makes a source of nutrients for both adult bees and larvae. The beekeepers collect bee pollen using traps that enable to separate pellets from insects’ legs [71–74].
Pollen food energy is rather high; for instance, bee pollen produced by Apis mellifera, collected in Thailand and containing mainly corn pollen, showed its value to be as much as 397.16 kcal/100 g . In 22 samples of bee pollens collected in Portugal, the obtained values ranged from 396.4 to 411.1 kcal/100 g . It is even named “only perfectly complete food”  or “the life-giving dust” .
3.1. Bee Pollen Composition
The components of bee pollen comprise of a great number of different substances including nutrients (proteins, carbohydrates, and lipids), amino acids (bee pollen is a rich source of leucine, isoleucine, and valine—branched, exogenous amino acids), fatty acids and their esters, vitamins (carotenoids, B, E, H, and folic acid), minerals (macro- and microelements), as well as phenolic organic compounds—flavonoids, phenolic acids, and their derivatives [2, 15, 42, 75, 77–83]. Additionally, the presence of different organic acids (oxalic, tartaric, malic, citric, succinic, acetic, lactic, and gluconic) was found, the latter exhibiting the highest concentration. Among inorganic components macroelements (sodium, potassium, calcium, and magnesium), microelements (iron, zinc, manganese, and copper) as well as some other metals (chromium, aluminium, strontium, tin, nickel, and vanadium) were detected. The content differed considerably in some cases, depending on the source region and plants, particularly as for gluconic acid, potassium, calcium, iron, manganese, and zinc .
Numerous studies concerning bee pollen included the determination of their detailed composition, particularly considering the biologically active compounds. The following flavonoids and their derivatives were identified as components of rape (Brassica campestris L.) bee pollen: quercetin, naringenin, kaempferol, and isorhamnetin as well as rutin and 3-O-glucosides of quercetin and kaempferol . In the bee pollen from Cistus sp. of Spanish origin, in turn, kaempferol, kaempferol-3-glucoside, quercitin, quercetin-7-rhamnoside, and isorhamnetin were found , whereas in Croatian Cystus incanus L. bee pollen, galangin, kaempferol, chrysin, and pinocembrin were detected . In some samples, the presence of herbacetin, myricetin, tricetin, luteolin, and 3-O-methylquercetin was proved . In Egyptian bee pollen, quercetin, rutin, catechin, epicatechin, kaempferol, apigenin, naringenin, and luteolin were identified . The glucosides of the following anthocyanins, delphinidin, petunidinm, and malvidin were found in bee pollen collected in Spain . According to Silva et al. the analysis of pollen loads collected by stingless bees Melipona rufiventris revealed the presence of different flavonoids, including dihydroquercetin, luteolin, quercetin, isorhamnetin, and isorhamnetin glucoside (isorhamnetin-3-O-(6″-O-E-p-coumaroyl)-β-D-glucopyranoside), which was detected in bee pollen for the first time .
As for phenolic acids on average, they constitute up to 0.19% of bee pollen and comprise of the derivatives of benzoic, cinnamic, and phenylacetic acids. Gallic acid (3,4,5-trihydroxybenzoic acid) is characterized by a great antioxidant activity .
Among the constituents of bee pollen, the following phenolic acids and their esters were reported to be identified: benzoic acid derivatives—p-hydroxybenzoic acid, gallic acid, syringic acid, vanilic acid, and protocatechuic acid—as well as cinnamic acid derivatives—p-coumaric acid, ferulic acid, caffeic acid, and their glycerol esters. Other more complicated derivatives like rosmarinic acid dihexoside as well as amide derivatives of hydroxycinnamic and ferulic acids were also found [14, 41, 71, 74, 77, 86].
3.2. Relationships between the Antioxidant Capacity of Bee Pollen and Its Composition
Bee pollen antioxidant properties have been investigated in many in vitro studies using DPPH, ABTS+, and FRAP methods. It is well known that the antioxidant capacity of bee pollen is dependent on its content. But the numerous studies, which have been carried out with the aim of determining the composition and properties of different bee pollen samples, proved a considerable diversity of the obtained results. Some studies have shown a strong positive correlation between the total content of phenolic compounds and antioxidant capacity of bee pollen [79, 81], whereas others found no considerable relationships . In the next study , in turn, not phenolic compounds but phenylpropanoid content was found to be correlated with the total antioxidant activity measured by the inhibition of linoleic acid peroxidation. According to Sousa et al. , in turn, flavonols may act as both antioxidants and prooxidants in their reduced and oxidized forms, respectively, whereas anthocyanins act as prooxidants. It has also been found that both content and properties of bee pollen are dependent on the kind of its plant source as well as the conditions of the plants growing like soil or climate. The time of harvesting creates an additional factor affecting these properties [2, 75, 76, 79, 80]. The potential influence of some kind of treatment (freezing as well as freezing and subsequent dehydratation) on the content and properties of bee pollen was also reported. While the chemical composition was not affected by freezing or freezing and subsequent drying, the antioxidant activity was enhanced by freezing and additional drying. The researchers attributed the observed effects to a moisture decrease, leading to antioxidants concentration . The differences in polyphenolic compounds, in total as well as particular types, were also found, showing considerable dispersion, for example, LeBlanc et al.  reported that mimosa bee pollen contained 34.85 mg/g of polyphenolics expressed as gallic acid equivalents, while in the yucca one, only 19.48 mg/g, and in the palm one, 15.91 mg/g were found. The flavonol content in Pyrus communis bee pollen was found to be 1349 mg/100 g, but in the Lamium purpureum one, it reached only 171 g/100 g . In different samples of bee pollen collected in northeastern Brazil in the period of nine months (January–November), flavonoid profiles were found to differ, depending on the time of harvesting and the predominant pollen type .
Similar to the case of propolis, the research has shown that the type of the extraction solvent used may affect the properties of the pollen extract to a considerable degree (Table 1). This is connected with different solubilities of particular components of bee pollen in solvents of diverse polarities. It was proved that the application of nonpolar solvents resulted in extracts of very low antioxidant activity, whereas the polar ones allowed obtaining the better antioxidant properties. However, considerable differences were observed even in the case of the application of solvents of similar polarity [11, 41, 42]. The optimal condition for bee pollen extraction was studied by Kim et al. . In their experiment, the total extract obtained by extraction with 80% methanol (twice) was then successively partitioned using solvents of different polarities: n-hexane, dichloromethane, ethyl acetate, and n-butanol. Ethyl acetate and n-butanol fractions exhibited the greatest activity, so in the next step, the optimal conditions of extraction were estimated by response surface methodology using the Box-Behnken design (BBD) with three-level three-factor. The variables were ethyl acetate concentration in methanol, temperature, and time. The solvent concentration proved to exhibit the greatest impact, and the optimal parameters were established as follows: 69.6% ethyl acetate in methanol, 10.0°C and 24.2 h. The calculated values were confirmed experimentally, as the extract obtained under the theoretically estimated conditions showed the antioxidant activity and tyrosinase inhibition very similar to those predicted by statistical methods . The dependence of extract properties on the used extraction solvent was also confirmed in the animal research. In rats with induced hind paw edema, the oral administration of bee pollen bulk showed mild suppressing properties, and water extract had practically no effect, while ethanol extract displayed the greatest effectiveness .
3.3. Bee Pollen Role in Mitigation of Chemotherapy Side Effect
Bee pollen has been found both to alleviate the deterioration of antioxidant barrier and instead of nad to inhibit lipid peroxidation process following chemotherapy.
Huang et al.  found that the intraperitoneal treatment with cisplatin resulted in the extensive deterioration of liver and kidney functions. This harmful effect involved a significant increase in the concentration of a lipid peroxidation marker MDA and iNOS as well as a well-marked depletion of activities of chosen antioxidant enzymes. However, the additional intragastrical pretreatment with Schisandra chinensis bee pollen was able to alleviate these effects in a dose-dependent way. The additional evidence for the antioxidant influence of bee pollen was the comparison of the described results with the effects observed in animals treated according to the same design with cisplatin and an acknowledged antioxidant vitamin—ascorbic acid—whose impact was comparable with that observed for bee pollen (Table 3). The relationships between antioxidant properties and protective influence of bee pollen against cisplatin were also confirmed by Tohamy et al. . In a study performed on cisplatin-exposed male mice, distinct symptoms of oxidative stress in organs (kidney, liver, and testis) were observed as the lipid peroxidation process was greatly intensified, while CAT activity and GSH concentration markedly depressed. However, the oral coadministration of Egyptian bee pollen water extract significantly alleviated prooxidant changes. Moreover, bee pollen alone decreased neither CAT nor GSH and distinctly inhibited lipid peroxidation in the kidney and testes. As the studied organs show a great vulnerability to the toxic action of cisplatin, the obtained results made the authors suggest the potential effectiveness of bee pollen at alleviating cisplatin-induced side effects. It seems to be worth noticing that in this case, the bee pollen proved to be effective even when administered after cisplatin application. The experiment performed by scientists from Malaysia supported the abovementioned findings. According to the authors, the methanol extract of bee pollen of Malaysian stingless bee (Lepidotrigona terminata (L. terminata)), displaying a distinct, dose-dependent antioxidant activity, was also effective for the antiproliferation of cells. Such an effect was observed in the case of both cancer (MCF-7) and normal (L929) ones with the IC50 value being much lower for cancer cells. Then the effect of cisplatin alone and in cotreatment with bee pollen extract was studied on MCF-7 cells. Cell proliferation was distinctly inhibited by cisplatin, and additional bee pollen revealed a potentializing influence on cisplatin action. In the next stage, the analysis of the influence of bee pollen and cisplatin combination on MCF-7 cell line was performed using CompuSyn software to evaluate if these agents work in an antagonistic, synergic, or additive way. The statistical analysis allowed the authors to suggest that these two substances acted in synergistic way. In conclusion, the researchers suggested the possibility of the application of the studied bee pollen, capable of aiming at potentiating the effectiveness of the therapy and allowing the decrease of the dose of chemoprotective drugs  (Table 3).
ALT: alanine aminotransferase; AST: aspartate aminotransferase; CAT: catalase; GSH: reduced glutathione, iNOS: inducible nitric oxide synthase; MDA: malondialdehyde; NO: nitrogen oxide; RBC: red blood cell; SOD: superoxide dismutase; ↓: decrease; ↑: increase; ∗∗the effect depended on used dose.
3.4. Bee Pollen as a Protective Agent against Prooxidants’ Toxicity
Antioxidant properties of bee pollen encouraged the research concerning its application as an agent preventing or alleviating harmful oxidative processes occurring in organisms or caused by different factors. The performed studies included interesting, diverse issues and resulted in considerably promising findings.
Turkish scientists investigated bee pollen as a protective agent against carbon tetrachloride hepatotoxicity. The results were additionally compared with those obtained for silibinin, an active component of silymarin (a plant-origin substance used in hepatic disorder cure). All the applied treatments caused a decrease in body weight gain. However, this effect was the least in the case of the coadministration of CCl4 and the higher dose of bee pollen. A significant enhancement of liver injury markers—plasma activity of transferases ALT and AST observed in CCl4-exposed rats—was considerably alleviated in animals cotreated with both silibinin and bee pollen. Furthermore, the effect of the higher bee pollen dose was not markedly different from that observed in the case of silibinin. Liver and plasma MDA were found to be significantly increased by CCl4 exposure, and again, both studied protective agents were capable of reversing this effect, although that in liver silibinin was more effective. The SOD activity in plasma, RBC, and liver was depressed in CCl4-exposed rats, and in this case, both silibinin and bee pollen proved to lack protective influence. As chestnut bee pollen was found to contain antioxidants and a substantial antioxidant capacity measured by FRAP and DPPH methods, the authors suggested the possibility of replacing silibinin by bee pollen in liver disorders cure, all the more because the harmful effects were observed in silibinin-treated animals—decrease in body weight gain, severe diarrhea, and, consequently, mortality  (Table 3).
Bee pollen was also shown to alleviate aflatoxin–induced oxidative processes in spleen by a decrease in the H2O2 level accompanied by GSH enhancement and NO proper generation .
In another animal study, bee pollen was investigated with regard to its possible application as an agent alleviating stress induced by exercise. Taking into account the fact that nutrients contained in bee pollen are barely absorbed in the gastrointestinal track due to the tough coat enclosing the components inside and making digestion difficult to proceed, the authors carried out a very interesting comparison of the neat and processed monofloral Indian mustard bee pollen. The processed one was obtained by mixing with an edible lipid-surfactant mixture (Captex 355 and Tween 80 in different ratios). The composition of the lipid-surfactant mixture influenced the total polyphenol content in the obtained processed samples, with the ratio of 1 mg of bee pollen : 500 mg of Captex 355 : 750 mg of Tween 80 showing the highest value. For this reason, that sample was chosen for further studying using an animal model as a protective agent against oxidative changes caused by exercise. In rats subjected to chronic exercise, the distinct evidence of oxidative stress was shown as SOD, and GSH were found to be markedly decreased, while MDA and NO significantly increased in the gastrocnemius muscle. Additionally, exercised animals displayed significantly decreased body and gastrocnemius muscle weights compared to the control. All these exercise-induced changes were partially reversed by oral treatment with both neat and processed bee pollen in a dose-dependent way, and the processed one proved to have much greater efficiency. Furthermore, the processed bee pollen, given alone to nonexercised animals, generally did not substantially affect the studied parameters in comparison with the control. The authors concluded that processing improved the availability of bee pollen nutrients and subsequently all beneficial effects  (Table 3).
Bee pollen has also been found to show some protective effect against oxidative damage observed in fish environmentally exposed to tebuconazole (a fungicide of high toxicity to aquatic organisms), but the obtained results were not unambiguous. Tebuconazole caused a considerable intensification of lipid peroxidation in chosen organs and a decrease in liver SOD. Additional bee pollen considerably reversed these effects. However, in the case of CAT, the obtained results were not so promising. Tebuconazole alone enhanced its activity in the liver and brain and showed no significant effect in kidney. The cotreatment with bee pollen displayed diverse effects, depending on dose and organ, with no determined tendency. But the most important fact was a significant CAT decrease versus control observed in the kidney and brain of fish exposed to higher concentrations of bee pollen. Furthermore, bee pollen alone also depressed CAT in those organs compared to control .
Almaraz-Abarca et al.  investigated the properties of bee pollen from mesquite (Prosopis juliflora) collected in Mexico and also received inconsistent results. Bee pollen extracts of two flavonol concentrations prevented lipid peroxidation observed in the liver of mice exposed to bromobenzene but the results reached statistical significance only in the case of higher dose. However, the extract of higher concentration given alone caused a significant intensification of liver lipid peroxidation in mouse, comparably with the one observed in bromobenzene-treated animals. Interestingly, the extract of lower concentration showed a great antioxidant effect as lipid peroxidation in this case was even decreased when compared to the control with no treatment. The authors concluded that in the absence of any oxidative stress-inducing factor, the administration of the high concentration of flavonols itself may induce oxidative damage occurrence. According to the authors, the confirmation of such an assumption could be the reports revealing that both polyphenols and an acknowledged antioxidant vitamin C may act as prooxidants in the presence of transient metal ions. Despite the similarity of the effects, the authors do not postulate the similarity of the mechanism of prooxidant influence of flavonoids and vitamin C. However, these outcomes show the necessity of proper precaution in the application of bee pollen, particularly in considering the dose (Table 3).
Similar conclusions were drawn from the experiment performed by Sousa et al. . Studying bee pollen from Echium plantagineum L., they used three different substances: its extract enriched in flavonols (fraction I), its extract enriched in anthocyanins (fraction II), and the combination of both extracts (the whole extract). Both I and II extracts contained kaempferol glucosides, and additionally in fraction II anthocyanins, glucosides of delphinidin, petunidin, and malvadin were detected. All three extracts were studied in vitro considering their influence on viability, reactive species, and antioxidants in Caco-2 cells. Interestingly, the extracts exhibited varied activity under different conditions. As for cells not subjected to any factor, neither fraction I nor fraction II caused any changes in cell viability measured by MTT assay, while the whole extract containing the combination of flavonols and anthocyanins, used in high concentration (20 mg/mL), caused a significant cellular viability depression. The effect of pretreatment with bee pollen extracts on the viability of cells induced by butyl hydroperoxide (t-BHP), whose presence stimulated reactive oxygen species production, was also evaluated. Herein, fraction II used in higher concentrations (2.5–20 mg/mL) and the whole extract (2.5–10 mg/mL) intensified t-BHP-induced harmful effect, while the highest concentrations of fraction I showed some insignificant but distinct protective effect. Additionally, the percentage values of cell viability, obtained for the whole extract, applied in concentration of 20 mg/mL, were the same, regardless of t-BHP presence or absence. These outcomes allowed the authors to suggest that anthocyanins acted as prooxidants, while flavonols supported antioxidant barrier but, in their oxidized forms, might also contribute to prooxidant processes. Lower concentrations of fractions I and II were also efficient at decreasing reactive species level. Interestingly, high concentration (20 mg/mL) prevented reactive species production only after a short t-BHP exposure. Along with the exposure, lengthening fraction II was proved to be ineffective, while fraction I began to act as a prooxidant as reactive species generation was shown to be enhanced. The whole extract did not show a significant antioxidant efficacy, and the higher concentrations exerted even prooxidant effect, particularly after a longer time of t-BHP exposure. Next, reduced glutathione was determined in the cells treated with different concentrations of the studied extracts, with and without subsequent exposure to t-BHP. The only effects were observed in cells exposed to t-BHP—a significant GSH increase after pretreatment with 20 mg/mL of the whole extract and a slight enhancement after using higher doses of fraction I. The authors tried to explain those complex observations pointing to GSH participation in t-BHP defusing, the bioactivation of t-BHP by cytochrome P450 as well as the inhibition of the influence of flavonoids (mainly anthocyanins) on cytochrome P450 enzymatic activity, the capacity of anthocyanins for being transformed into radicals, as well as the ability of t-BHP to form species more active than those produced by the process of its biotransformation. Concluding, the authors underlined the necessity of taking the proper precautions in using bee pollen, particularly considering the dose.
3.5. Bee Pollen in Cosmetics
The beneficial influence of bee pollen on skin condition has been known from ancient times. Recently, as the return to natural medicine agents is being observed, some studies have been carried out with the aim of clarifying the mechanism of these effects.
Sun et al. , in their experimental study, confirmed the possibility of bee pollen using in skin therapy, connected with its antioxidant ability. Chinese scientists studied composition, antioxidant activity, as well as its influence on the melanogenesis of two rape bee pollen extracts containing free or bound phenolics. Both extracts exhibited antioxidant capacity measured by DPPH, ABTS, and FRAP methods, although the free phenolic one proved to be much more effective as an antioxidant. In the next stage of the study, the effect on melanin synthesis was investigated. Tyrosinase activity was inhibited in a dose-dependent way by both extracts with the free one being more effective. Since some phenolic compounds also showed the same effect, the authors assumed the existence of some relationship between phenolic profile and inhibitory influence on tyrosinase activity. The tyrosinase inhibition was studied considering the fact that melatonin, despite its protective role for the skin, in excessive amounts, may itself exert harmful effects like reactive oxygen species generation and pigmentation. The effect of free phenolic extract of bee pollen on melanogenesis was also studied using B16 mouse melanoma cells. The studied substance decreased intracellular tyrosinase activity and melanin relative content in a very distinct, dose-dependent way. Moreover, taking into account the connection between the melanogenesis and generation of oxygen reactive species and consequently the role of intracellular reducing activity in melanogenesis regulation, GSH/GSSG value was measured. Free phenolic bee pollen extract again showed a high effectiveness at increasing reducing power by enhancing intracellular GSH/GSSG ratio, indirectly contributing to the depression of melanin synthesis. All the presented results point to the usefulness of bee pollen in protecting the cell against abnormal melanogenesis, which cannot be overrated as melanin is responsible for numerous skin disorders, from freckles up to malignant melanoma . The usefulness of bee pollen in manufacturing cosmetics protecting the skin against hyperpigmentation and oxidative stress was also confirmed by Korean scientists .
4. Royal Jelly
Royal jelly is a secretion from mandibular and hypopharyngeal glands of young bees of the Apis mellifera species . This is a white or yellowish cream substance that makes food for young bee larvae (but no longer than three days, and then they are fed with a mixture of pollen, nectar, and honey) and the only food for the queen in both the larval and adult stages [95–97]. This difference in the way of feeding is considered as the main factor responsible for the differentiation in the development of bee workers and the queen. In comparison to the workers’ food, the royal jelly contains less water and four times more sugars, more proteins, and different concentrations of some mineral salts . This unique composition of royal jelly leads to changes in gene expression (most probably through epigenetic mechanisms) which allows, for instance, full ovarian development to proceed . Thanks to royal jelly, the queen could live up to five years (workers usually live about 45 days) and lay about 2000–3000 eggs a day . For commercial use, royal jelly is collected from the queen’s cells, as they are the richest sources of this product—it is produced in a much larger amount than queen larvae are able to consume . According to some sources, the annual production of royal jelly amounts to several thousand tons—about 2000 tons are produced only in China .
4.1. Royal Jelly Composition
From the chemical point of view, the royal jelly is an emulsion of proteins, sugars, and lipids in water. Moreover, it contains about 1.5% mineral salts (mainly copper, zinc, iron, calcium, manganese, potassium, and sodium salts) and small amounts of flavonoids, polyphenols, and vitamins (biotin, folic acid, inositol, niacin, pantothenic acid, riboflavin, thiamine, and vitamin E) [95, 99–101]. Among RJ, flavonoids can be distinguished: flavanones (hesperetin, isosakuranetin, and naringenin), flavones (acacetin, apigenin, and its glucoside, chrysin, and luteolin glucoside), flavonols (isorhamnetin and kaempferol glucosides), and isoflavonoids (coumestrol, formononetin, and genistein) .
The water content in the royal jelly is 50–70% [23, 95]. The total sugar content fluctuates between 7 and 21.2% and mainly consists of fructose and glucose [95, 99, 103]. Fructose and glucose together account for 90% of all sugars [99, 104]. Sucrose is always present but often in variable concentrations (2.86% according to Kanelis et al. , 2.1% according to Kolayli et al. , 0.5–2% according to Oršolić , and 0.2% according to Wytrychowski ). Studies have also revealed the presence of other oligosaccharides, such as trehalose, maltose, gentiobiose, isomaltose, raffinose, erlose, and melezitose [103, 104].
The total protein content in the royal jelly, according to different researchers, varies between 8 and 9% [23, 104, 105]. The electrophoretic analysis of royal jelly from two bee subspecies—Apis cerana japonica and Apis mellifera—revealed 21 different bands of proteins on the gel of which 14 bands were common to both subspecies . The so-called major royal jelly proteins (MRJPs) represent about 90% of the total protein content . Interestingly, according to Kamakura , the ability of the royal jelly to modulate the development of female larvae may be partially related to the presence the most abundant protein—major royal jelly protein 1 (MRJP1). Silici et al.  pointed out that very important components of the royal jelly are free amino acids. Using the LC/MS method, they indicated that it contained amino acids such as lysine (the biggest amount—62.43 mg/100 g); proline (58.76 mg/100 g); cystine (21.76 mg/100 g); aspartic acid (17.33 mg/100 g); and less than 5 mg/100 g of valine, glutamic acid, serine, glycine, cysteine, threonine, alanine, tyrosine, phenylalanine, hydroxyproline, leucine-isoleucine, and glutamine. According to these scientists, the antioxidant activity of royal jelly may be related to the biological effect of free amino acids.
The total content of fats and fatty acids in the royal jelly is estimated to be in the range of 7–18% [95, 104]. Instead of carboxylic acids with 14–20 carbon atoms commonly found in animals and plants, the royal jelly contains short hydroxy fatty acids with 8–12 carbon atoms in the chain and dicarboxylic acids. About 80–90% of the fatty substance fraction is an extremely rare free fatty acid with an unusual structure. The major fatty acid is 10-hydroxydecanoic acid (10-HDA), whose presence has not been reported in any other natural raw material or even in any other product of apiculture . According to different investigators, the content of 10-HDA in the royal jelly ranges from 0.75 to 3.39% . It is noteworthy that this acid is considered as one of the most important components from which the royal jelly biological activity derives. Other carboxylic acids are 10-hydroxy-2-decenoic acid (10H2DA) and sebacic acid (SA) (Figure 4) .
Considering the antioxidant activity, very important ingredients of the royal jelly are flavonoids and phenolic compounds. According to Nabas et al. , the royal jelly contains 23.3 ± 0.92 GAE μg/mg total of phenolics and 1.28 ± 0.09 RE μg/mg of total flavonoids. Interestingly, Liu et al.  found higher contents of polyphenolic compounds (and also proteins) in the royal jelly harvested 24 hours than in that harvested 48 or 72 hours after collection from the larvae. Hence, the authors suggest that the harvesting time of royal jelly can affect the content of antioxidant compounds and, thus, the therapeutic potential of the product. The GC/MS analysis performed by Kanbur et al.  showed that the main phenolic compounds contained in the royal jelly were pinobanksin as well as organic acids and their esters, for example, octanoic acids, 2-hexenedioic acid and its esters, dodecanoic acid and its ester, 1,2-benzenedicarboxylic acid, and benzoic acid.
4.2. Royal Jelly as a Scavenger of Free Radicals
In the available data, there are some reports confirming the role of royal jelly as a scavenger of free radicals [104, 110, 112, 113]. For instance, Liu et al.  investigated the antioxidant properties of the royal jelly expressed as the radical-scavenging effect upon DPPH, hydroxyl, and superoxide radicals. The researchers also evaluated its reducing power, inhibition effect upon linoleic acid oxidation, and superoxide dismutase activity. The obtained results were compared depending on the larval age (1-, 2-, or 3-day old) and time of harvest after the larval transfer from the queen cell cups to the bee hives (24, 48, and 72 h). The authors noted DPPH radical-scavenging effect (in the range of 43.0–62.8%) as well as the inhibitory effect on the superoxide radical formation (ranging from 23.9 to 37.4%) and on hydroxyl radical formation (48–68%). Moreover, the royal jelly sample demonstrated an inhibitory effect on linoleic acid peroxidation (8.6–27.9%). In all cases, the strongest scavenging effect of RJ was noted in the samples taken from the youngest larvae (1 day old) transferred into bee hives for the shortest time (24 h). In addition, the same royal jelly samples proved to have the strongest reducing power. On the other hand, the SOD activity of the royal jelly collected at 72 h after larval transferring of 3-day old larvae was significantly higher than that of the others. Accordingly, the authors suggested that the superoxide radical-scavenging effect of the royal jelly might be attributed to antioxidative compounds different from SOD.
Guo et al.  found strong antioxidant properties of peptides obtained after the hydrolysis of royal jelly proteins using protease N. The antioxidative properties of the obtained peptides were examined in terms of mechanisms such as hydrogen peroxide, superoxide, and hydroxyl radical-scavenging activities and metal-chelating activity. Twelve obtained peptides showed strong hydroxyl radical-scavenging activity, and three dipeptides containing Tyr residues at their C-termini (Lys-Tyr, Arg-Tyr, and Tyr-Tyr) had strong hydrogen peroxide-scavenging activity. However, in this study, no significant metal-chelating and superoxide anion-radical-scavenging activities of the isolated peptides were noted. The authors concluded that di- and tri-peptides could possess greater antioxidative activity than their constituent amino acids.
4.3. Antioxidant Effect of Royal Jelly in Human and Animal Diabetes Mellitus Model
Despite antioxidant properties of the royal jelly found in both in vitro and in vivo models, there are only a few human studies confirming its effectiveness. The research recently conducted concerned its influence on the parameters associated with diabetes and oxidative stress in people with diabetes mellitus type 2 [114, 115]. In the study conducted by Pourmoradian et al. , 50 female volunteers with type 2 diabetes were randomly supplemented with RJ (1000 mg once a day) or placebo for 8 weeks. Before and after the intervention, glycemic and antioxidative-oxidative blood parameters were determined. After the supplementation decreased fasting blood glucose (FBG) and serum glycosylated hemoglobin (HbA1c) levels as well as increased insulin concentration were noticed in the royal jelly-supplemented group in comparison with the placebo one. Moreover, the supplementation caused a significant increase in erythrocyte SOD and GPx activities as well as a decrease in MDA concentration. Similar results were reported by Shidfar et al. . In their study, 46 type 2 diabetic patients were randomly assigned to royal jelly (1000 mg, 3 times a day, for 8 weeks) or placebo -supplemented groups. In the supplemented group, decreased homeostasis model assessment for insulin resistance (HOMA-IR) and increased total antioxidant capacity in comparison with the placebo group were noted. Also in studies using an animal model of diabetes, the improvement of oxidative-antioxidant (MDA, CAT, and ferric-reducing properties of plasma (FRAP)) and biochemical parameters (alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and fasting blood glucose (FBG)) as well as histopathological changes (tubular differentiation index, mononuclear immune cells, tunica albuginea thickness, seminiferous tubules diameter, Johnsen’s score, spermiogenesis index, Sertoli cell index, and meiotic index) were observed after royal jelly supplementation [116, 117]. The authors suggested that their results confirmed the role of reactive oxygen species, even if only secondary, in the pathogenesis of type 2 diabetes. According to them, the royal jelly can ameliorate insulin resistance via antioxidant effect. Based on their results, the authors stated that supplementation with the royal jelly might be beneficial for diabetic patients, but further studies are necessary to clarify the exact mechanism of RJ influence on diabetic parameters.
4.4. Antioxidant and Neuroprotective Effects of Royal Jelly
There are several studies that focused on the relationship between the antioxidant and neuroprotective effects of royal jelly, in the literature data. Mohamed et al.  investigated the possible neurotoxic effect of tartrazine, a commonly used synthetic azo dye, as well as the potential modulatory role of royal jelly. The group of rats receiving only tartrazine showed not only disturbances of antioxidant biomarkers but also numerous apoptotic cells in the brain cortex and significant decrease in the concentration of the brain neurotransmitters (GABA, dopamine, and serotonin). The authors revealed that the cotreatment of rats with royal jelly improved antioxidant biomarkers as well as neurotransmitter levels. Interestingly, royal jelly also had an activating effect on the central nervous system represented by the reduced degree of damage and apoptosis of brain tissue. The authors concluded that a component responsible for these changes could be 10-hydroxy-2-decenoic acid, because it was demonstrated that in addition to its antioxidative properties, 10H2DA could support the generation of neurons.
The relationship between the neutralizing effect of royal jelly on oxidative stress and neurotoxicity was also sought by Aslan et al. . The researchers revealed that royal jelly diminished the secondary neuronal damage after experimental spinal cord injury in rabbits. In this study, the authors noticed that the treatment with royal jelly prevented lipid peroxidation and augmented endogenous enzymic or nonenzymic antioxidative defense systems levels (Table 4). Moreover, royal jelly treatment significantly decreased the apoptotic cell number induced by spinal cord injury. Because the authors noted statistically higher levels of ascorbic acid in the royal jelly group (laminectomy +100 mg/kg RJ p.o.) in comparison with the control group (laminectomy + single dose of 1 mL/kg saline p.o.), they suggested that the protective effect of royal jelly against oxidative stress might be related to restoration of ascorbic acid availability.
10H2DA: 10-hydroxy-trans-2-decenoic acid; CAT: catalase; FRAP: iron reduction capacity; G6PDH: glucose-6-phosphate dehydrogenase; GPx: glutathione peroxidase; GR: glutathione reductase; GSH: reduced glutathione; G6PDH: glucose-6-phosphate dehydrogenase; HPO-DAEE: hydroperoxy-2-decenoic acid ethyl ester; HO-1: heme oxygenase-1; iNOS: inducible nitric oxide synthase; MDA: malondialdehyde; NO: nitric oxide; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; Nrf2/ARE: nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant responsive elements (AREs); SOD: superoxide dismutase; TAC: total antioxidant capacity; TBARS: thiobarbituric acid reactive substances; TNF-α: tumor necrosis factor alpha; TTM: total thiol molecules; ↓: decrease; ↑: increase; ∗∗the effect depended on used dose.
A study conducted by Teixeira et al.  also suggested the existence of antioxidant and neuroprotective effects of royal jelly but in the resistant and cold stress condition (Table 4). The authors postulated that the antioxidant activity of royal jelly, observed in the region of striatum, might correspond to adenosine monophosphate (AMP) N1-oxide—the unique compound of RJ—which can regulate neuronal functions through receptors predominantly expressed in striatum (A2A adenosine receptors). They speculated that the activation of these receptors can prevent radical formation and apoptosis.
4.5. Alleviating Effect of Royal Jelly on Oxidative Stress
Studies evaluating the alleviating effect of royal jelly on oxidative stress were performed using several in vivo models. The antioxidant effect of royal jelly in cisplatin-induced spermiotoxicity and nephrotoxicity in rats was investigated by Silici et al. [100, 121]. The researchers attributed antioxidant properties of royal jelly to the presence of substances such as 10-hydroxy-2-decenoic acid and free amino acids including proline (which is suggested to act as an antioxidant due to hydroxyl radical-scavenging activity) as well as cystine and cysteine (participating in the synthesis of effective cellular antioxidant—glutathione). The influence of royal jelly on adverse effects generated by the administration of sodium fluoride at high doses in mice was assessed by Kanbur et al. . The authors explained that the antioxidant royal jelly effect could be associated not only with radical-scavenging effect but also with another indirect effect based on the inhibition of enzymes that catalyze the peroxidation of endogenous lipids as well as the gene expression of cytochrome P450, which is one of the intracellular source of H2O2, O2·− and HO· radicals . Other studies also demonstrate the antioxidant effect of royal jelly in an animal model under oxidative stress condition induced by substances like carbon tetrachloride (industrial solvent) , azathioprine (immunosuppressive drug) , bleomycin , methotrexate , paclitaxel , taxol  (chemotherapeutic agents), and oxymetholone (synthetic androgen analogue) . In all mentioned studies, the antioxidant effect of royal jelly consisted of a positive effect on the oxidative-antioxidative parameters (Table 4). In addition, some researchers reported other therapeutic effects of royal jelly such as hepatoprotective [123, 124], cardioprotective , or anti-inflammatory [113, 130] ones. The postulated hypotheses explaining the antioxidant effect are the restoration of ascorbic acid availability by royal jelly, regulation of retinol loss , antioxidant effect of some free amino acids , or radical-scavenging activities of RJ and its component .
The antioxidant effect of royal jelly has also been confirmed by in vitro studies. For instance, the aim of the study by Inoue et al.  was to investigate protective effects of royal jelly fatty acid derivative (4-hydroperoxy-2-decenoic acid ethyl ester (HPO-DAEE)) on oxidative stress-induced cell death using human neuroblastoma SH-SY5Y cells (Table 4). The researchers noted that the pretreatment with HPO-DAEE protected against 6-hydroxydopamine- (6OHDA-) induced cell death by increasing the expression of antioxidant enzyme—heme oxygenase-1 (HO-1) mRNA—through Nrf2-ARE signaling. Interestingly, the authors revealed that the treatment with HPO-DAEE rapidly induced reactive oxygen species generation in SHSY5Y cells. In conclusion, these results suggested that sublethal oxidative stress caused by HPO-DAEE is essential for the activation of this pathway, which is aimed at antioxidant defense. Moreover, the authors observed that HPO-DAEE promoted the phosphorylation of eukaryotic initiation factor 2a (eIF2a), and the subsequent nuclear accumulation of the activating transcription factor-4 (ATF4). The ATF4 pathway is known to be activated under several stress conditions. It is supposed that the interaction of the Nrf2-ARE pathway with the eIF2a-ATF4 pathway augments HO-1 expression.
The investigation of protective effect of royal jelly in the redox state of ovine oocytes matured in vitro, and embryonic development following in vitro fertilization was performed by Eshtiyaghi et al. . The authors explained that the improvement of oocyte maturation in the case of cells supplemented with royal jelly might be associated with the improvement of redox status. One of the objectives of this study was to examine the effect of different concentrations of royal jelly (2.5, 5, and 10 mg/mL of maturation media) on the in vitro maturation and glutathione (GSH) level of ovine oocyte as well as the abundance mRNA of antioxidant enzymes in both oocyte and cumulus cells. Moreover, the authors investigated glucose metabolism-related genes in cumulus cells. The parameters were evaluated following 24 hours of in vitro maturation. The authors noted that the dose of 10 mg/mL of RJ not only led to an increase in the number of oocytes but also caused an increase in the intracellular GSH content compared to the control group and the group receiving the lowest dose of royal jelly. In addition, supplementation with 10 mg/mL of royal jelly increased the mRNA GPx in both oocyte and cumulus cells as well as SOD expression in the cumulus cells. However, royal jelly supplementation did not influence mRNA CAT level in both oocyte and cumulus cells. Moreover, the increased expression of phosphofructokinase and glucose 6-phosphate dehydrogenase in the cumulus cells after the addition of royal jelly to the maturation media indicated that the observed protective effect of royal jelly might be related to the activation of glucose metabolic pathways in the surrounding cumulus cells.
The negation of the above results seems to be a study carried out by Filipič et al. . The purpose of this study was to investigate the influence of royal jelly and its bioactive component—10H2DA—and human interferon-alpha (HuIFN-αN3—a protein with antiviral, antiproliferative, and antitumor activities—on the proliferation of human colorectal adenocarcinoma cells (CaCo-2) and the oxidative stress parameters—GSH and MDA concentration. Royal jelly and HuIFN-αN3 applied at 2 : 1 ratio and royal jelly applied in combination with 10H2DA (2 : 1 ratio) caused a decrease in the level of GSH and increase in lipid peroxidation indicator level (MDA) in CaCo-2 cells in comparison with the control group. On the other hand, it was observed that these combinations had the highest antiproliferative effect. The authors suggested that antiproliferative effects of RJ, HuIFN-αN3, and 10H2DA on the CaCo-2 cells could be connected not only with the induction of apoptosis and cytotoxicity but also with their influence on the prooxidative-antioxidative balance.
Attempts to explain the alleviating mechanism of royal jelly’s action on nitrosative stress were made by Sugiyama et al. . Researchers examined the ability of 10H2DA to inhibit LPS-induced nitric oxide (NO) generation using the RAW264 murine macrophage cell line. Their study was based on the fact that LPS stimulates the production of interferon- (IFN-) β, induction of IFN regulatory factor-1, and activation of IFN-stimulated response element. These factors are required for iNOS (nitric oxide synthases) induction. The authors noted that 10H2DA not only inhibited LPS-induced nitric oxide (NO) generation but also restrained IFN-β-induced nuclear factor- (NF-) κB activation and tumor necrosis factor- (TNF-) α production. The authors concluded that 10H2DA inhibited LPS- and IFN-β-induced NO productions via the inhibition of NF-κB activation induced by LPS or IFN-β. Similar studies have been carried out by Takahashi et al. . Using the same cell line, authors noted the inhibition of interferon-γ-induced NO production by 10H2DA through the inhibition of interferon regulatory factor-8 induction (Table 4).
5. Comparison of the Antioxidant-Related Potential of Propolis, Bee Pollen, and Royal Jelly
Numerous in vitro studies using DPPH, ABTS+, FRAP, ORAC methods, and so on have confirmed the antioxidant potential of bee products [3, 19, 20, 31, 35, 36, 38, 79, 81, 85, 110]. In this part, we will try to compare the antioxidant capacity of propolis, bee pollen, and royal jelly among each other.
It is well known that the antioxidant capacity of bee products is strongly dependent on their chemical composition. In general, the antioxidant activity of poplar propolis is believed to be largely influenced by both total polyphenol and total flavonoid contents, while the Brazilian one by phenolic compounds but different ones than flavonoids [3, 34–36, 38]. In the case of bee pollen, research has shown divergent results; some have shown a strong positive correlation between the total content of phenolic compounds and antioxidant capacity [79, 81], whereas others have found no considerable relationships [71, 87, 136]. Leja et al.  suggested, in turn, that not phenolic compounds but bee pollen phenylpropanoids are responsible for the inhibition of linoleic acid peroxidation. As for royal jelly, its antioxidant properties are mainly attributed to the presence 10-hydroxydecanoic acid and free amino acids including proline as well as cystine and cysteine following phenolic compounds [100, 102, 121].
Basing on literature data, propolis seems to be the most powerful antioxidant among all the analyzed bee products. The comparison of the phenolic compounds’ content seems to confirm the above thesis—the highest amount of both total phenols and flavonoids has been found in propolis followed, in order, by bee pollen and royal jelly. However, it should be emphasized that royal jelly also contains other compounds possessing antioxidant character. The next confirmation of the above thesis are the results obtained by Nakajima et al. . In their study, the rank order of antioxidant potencies measured by the hydrogen peroxide, superoxide anion, and hydroxyl radical-scavenging capacities was as follows: water propolis extract, ethanol propolis extract, and ethanol pollen extract, but neither royal jelly nor 10-hydroxy-2-decenoic acid (10-HDA) had any effects. So both propolis extracts showed much greater antioxidant activity than the bee pollen one, and surprisingly, the water propolis extract was much more effective that the ethanol one.
On the other hand, in the in vivo study, waterborne bee products (including royal jelly, bee pollen, and propolis) were shown to be able to reverse the oxidative damage caused by exposure to tebuconazole. They affected the brain, kidney, and liver lipid peroxidation, protein carbonylation, and antioxidant markers. All studied products were effective, but the effects were dependent on doses and organs, and no clear trend was observed . Similar results were observed by Turkish researchers  who noticed the highest antioxidant capacity as well as total phenolic and flavonoid content in propolis, followed, in order, by pollen, honey, and royal jelly. Despite very significant differences in both phenolic content and antioxidant activities measured using FRAP and DPPH methods, in an in vivo study, all products revealed similar hepatoprotective activity against CCl4-induced hepatic damage in rats. All of them had the very similar effect on liver parameters and antioxidant/oxidant markers with only a very slight advantage in the case of propolis. The authors suggested that these results could be explained through their bioavailability to the treated animals. It should be underlined that in the case of bee pollen, research has shown not only its antioxidative but also its prooxidative action. For example, in LPS-stimulated macrophages, the bee pollen extract was shown to efficiently scavenge nitric oxide, although against superoxide, it behaved as antioxidant at lower concentrations and as prooxidant at higher concentrations . To the best of our knowledge, prooxidative properties of propolis and royal jelly have not been found. On the other hand, some studies have found that bee pollen along with propolis exhibits strong antioxidant effects, while royal jelly had no effect.
As for the mechanism underlying the potential antioxidant-related effects, the most studied is propolis. It has been shown the treatment with propolis and its common compound pinocembrin generates an increase in at least one of the enzymatic antioxidant pathway, namely, it induces the translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) to the nucleus and subsequent expression of antioxidant response element- (ARE-) mediated antioxidant genes such has HO-1 and γ-GCS [6, 62]. Moreover, propolis or pinocembrin was found to regulate the expression, on both the mRNA and protein levels, of genes encoding other antioxidant markers, including LOX-1, γ-GCS, GCLM, GCLC, and TrxR1 [6, 49, 56, 63, 66]. The royal jelly was noticed to affect HO-1 expression through Nrf2-ARE pathway as well as the expression of cytochrome P450, GPx, and SOD [122, 131, 132]. As for bee pollen, to the best of our knowledge, there is no information in the literature data on its influence on the expression of antioxidant-related genes. Furthermore, the mechanisms of bee products for the reversal of oxidative damage appear to involve the reduction of lipid peroxidation (MDA and TBARS) and oxidant parameters (e.g., ROS) as well as the augmentation of antioxidant enzyme activities (e.g., CAT, SOD, GPx, and GST). But this assumption is based on the fact that the treatment with bee products affects the level of the above parameters in blood and studied organs.
Propolis is also the most studied in cell and animal research. It is credited with having antioxidant–related neuroprotective and cardioprotective actions and is thus suggested as a protective agent against Alzheimer’s [47, 48] and Parkinson’s diseases  as well as atherosclerosis . The neuroprotective effect of royal jelly was also noted. All analyzed bee products have been tested in relation to the reduction of the negative effect of chemotherapy—in each case, the obtained results were promising [4, 5, 51, 90, 94, 121, 125, 127, 128]. The rest studies are focused on estimating the protective action of bee products against various harmful factors and drugs causing oxidative stress.
Although in vitro and animal studies seem to confirm the antioxidant-related protective effect of bee products, there are only a few studies performed on humans in the literature data [44–46, 114, 115]. The existing ones aim at evaluating the supplementation effect in healthy population or type 2 diabetic patients and involve propolis as well royal jelly. Herein, the obtained results are inconsistent. For example, propolis supplementation had a positive effect in men but not in women . As for diabetic patients, royal jelly seems to have a higher potential than propolis as it was shown to regulate the parameter associated with diabetes HOMA-IR , while propolis affected only oxidative-related parameters .
Undoubtedly, there is a gap in the literature data considering the evaluation of the bee products’ potential in human population. This results from the fact that bee products are characterized by very complicated biological matrix. Moreover, their composition varies depending on many factors, which are sometimes very difficult to control, that is, temperature. In fact, the chemical composition of each sample should be tested before being included in an in vivo study. This is very tedious, time-consuming, and troublesome. Therefore, researchers today are more likely to use the commercially available equivalents, for example, CAPFE or pinocembrin. This is not exactly a good direction since we should remember that the complex products may exert synergistic effects. For example, Almaraz-Abarca et al.  evaluated the potential of bee pollen and chosen phenolic compounds in the inhibition of lipid peroxidation in microsomal preparations of mouse liver and showed much higher effectiveness of bee pollen (about 5.5 times as high as quercetin alone, 3 times as its glucoside (quercitrin) alone, and 2.4 times as caffeic acid alone).
The aforementioned in vitro and animal studies seem to confirm the usefulness of using bee products (propolis, bee pollen, and royal jelly) as natural agents capable of counteracting the effects of oxidative stress underlying the pathogenesis of numerous diseases or disorders, such as neurodegenerative disorders, cancer, diabetes, and atherosclerosis, as well as negative effects of different harmful factors and drugs (e.g., cytostatic agents). However, studies on their role in humans are very limited, and the existing ones have aimed mostly at evaluating the effect of the supplementation of commercially available extracts of propolis or royal jelly in healthy people or type 2 diabetes. Unfortunately, in the available literature, there is a lack of studies considering this issue in the context of neurodegenerative disorders or cancers, although promising results were obtained in animal studies. This may result from the fact that particular samples of bee products may have different compositions, so it is difficult to draw a general conclusion concerning their potential therapeutic application without a detailed chemical analysis.
In conclusion, future studies concerning the question if bee products could be a promising adjuvant in the therapy of oxidative stress-related disorders or diseases in human seem to be advisable.
Conflicts of Interest
The authors declare that there is no conflict of interest regarding the publication of this paper.
- O. Yıldız, Z. Can, Ö. Saral et al., “Hepatoprotective potential of chestnut bee pollen on carbon tetrachloride-induced hepatic damages in rats,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 461478, 9 pages, 2013.
- B. Denisow and M. Denisow-Pietrzyk, “Biological and therapeutic properties of bee pollen: a review,” Journal of the Science of Food and Agriculture, vol. 96, no. 13, pp. 4303–4309, 2016.
- C. Sun, Z. Wu, Z. Wang, and H. Zhang, “Effect of ethanol/water solvents on phenolic profiles and antioxidant properties of Beijing propolis extracts,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 595393, 9 pages, 2015.
- S. Kumari, P. Naik, B. L. Vishma et al., “Mitigating effect of Indian propolis against mitomycin C induced bone marrow toxicity,” Cytotechnology, vol. 68, no. 5, pp. 1789–1800, 2016.
- M. Alyane, L. B. Kebsa, H. Boussenane, H. Rouibah, and M. Lahouel, “Cardioprotective effects and mechanism of action of polyphenols extracted from propolis against doxorubicin toxicity,” Pakistan Journal of Pharmaceutical Sciences, vol. 21, no. 3, pp. 201–209, 2008.
- X. Jin, Q. Liu, L. Jia, M. Li, and X. Wang, “Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells,” Cellular and Molecular Neurobiology, vol. 35, no. 3, pp. 323–333, 2015.
- R. Barros Silva, N. A. Santos, N. M. Martins et al., “Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats,” Neuroscience, vol. 233, pp. 86–94, 2013.
- H. Izuta, M. Shimazawa, K. Tsuruma, Y. Araki, S. Mishima, and H. Hara, “Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells,” BMC Complementary and Alternative Medicine, vol. 9, no. 1, article 45, 2009.
- G. Bazmandegan, M. T. Boroushaki, A. Shamsizadeh, F. Ayoobi, E. Hakimizadeh, and M. Allahtavakoli, “Brown propolis attenuates cerebral ischemia-induced oxidative damage via affecting antioxidant enzyme system in mice,” Biomedicine & Pharmacotherapy, vol. 85, pp. 503–510, 2017.
- N. Baltas, S. A. Karaoglu, C. Tarakci, and S. Kolayli, “Effect of propolis in gastric disorders: inhibition studies on the growth of Helicobacter pylori and production of its urease,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 31, Supplement 2, pp. 46–50, 2016.
- B. W. LeBlanc, O. K. Davis, S. Boue, A. DeLucca, and T. Deeby, “Antioxidant activity of Sonoran desert bee pollen,” Food Chemistry, vol. 115, no. 4, pp. 1299–1305, 2009.
- D. Ferreira, H. C. Rocha, L. C. Kreutz et al., “Bee products prevent agrichemical-induced oxidative damage in fish,” PLoS One, vol. 8, no. 10, article e74499, 2013.
- S. B. Kim, Y. H. Jo, Q. Liu et al., “Optimization of extraction condition of bee pollen using response surface methodology: correlation between anti-melanogenesis, antioxidant activity, and phenolic content,” Molecules, vol. 20, no. 11, pp. 19764–19774, 2015.
- J. de Florio Almeida, A. S. d. Reis, L. F. S. Heldt et al., “Lyophilized bee pollen extract: a natural antioxidant source to prevent lipid oxidation in refrigerated sausages,” LWT—Food Science and Technology, vol. 76, pp. 299–305, 2017.
- A. Rzepecka-Stojko, J. Stojko, A. Kurek-Górecka et al., “Polyphenols from bee pollen: structure, absorption, metabolism and biological activity,” Molecules, vol. 20, no. 12, pp. 21732–21749, 2015.
- J. Arct and K. Pytkowska, “Flavonoids as components of biologically active cosmeceuticals,” Clinics in Dermatology, vol. 26, no. 4, pp. 347–357, 2008.
- A. N. Panche, A. D. Diwan, and S. R. Chandra, “Flavonoids: an overview,” Journal of Nutritional Science, vol. 5, p. e47, 2016.
- R. De Paula, I. Rabalski, M. C. Messia, E.-S. M. Abdel-Aal, and E. Marconi, “Effect of processing on phenolic acids composition and radical scavenging capacity of barley pasta,” Food Research International, vol. 102, pp. 136–143, 2017.
- T. Bonamigo, J. F. Campos, A. S. Oliveira et al., “Antioxidant and cytotoxic activity of propolis of Plebeia droryana and Apis mellifera (Hymenoptera, Apidae) from the Brazilian Cerrado biome,” PLoS One, vol. 12, no. 9, article e0183983, 2017.
- T. Bonamigo, J. F. Campos, T. M. Alfredo et al., “Antioxidant, cytotoxic, and toxic activities of propolis from two native bees in Brazil: Scaptotrigona depilis and Melipona quadrifasciata anthidioides,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 1038153, 12 pages, 2017.
- F. de Lima Moreira, G. H. B. de Souza, I. V. Rodrigues, N. P. Lopes, and A. R. M. de Oliveira, “A non-Michaelian behavior of the in vitro metabolism of the pentacyclic triterpene alfa and beta amyrins by employing rat liver microsomes,” Journal of Pharmaceutical and Biomedical Analysis, vol. 84, pp. 14–19, 2013.
- C.-C. Wei, C.-H. Chang, and V. H.-C. Liao, “Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans,” Phytomedicine, vol. 36, pp. 118–125, 2017.
- S. Kolayli, H. Sahin, Z. Can, O. Yildiz, M. Malkoc, and A. Asadov, “A member of complementary medicinal food: anatolian royal jellies, their chemical compositions, and antioxidant properties,” Journal of Evidence-Based Complementary & Alternative Medicine, vol. 21, no. 4, pp. NP43–NP48, 2016.
- J. Makino, R. Ogasawara, T. Kamiya et al., “Royal jelly constituents increase the expression of extracellular superoxide dismutase through histone acetylation in monocytic THP-1 cells,” Journal of Natural Products, vol. 79, no. 4, pp. 1137–1143, 2016.
- C. Zuluaga, A. Martínez, J. Fernández, J. López-Baldó, A. Quiles, and D. Rodrigo, “Effect of high pressure processing on carotenoid and phenolic compounds, antioxidant capacity, and microbial counts of bee-pollen paste and bee-pollen-based beverage,” Innovative Food Science & Emerging Technologies, vol. 37, pp. 10–17, 2016.
- V. R. Pasupuleti, L. Sammugam, N. Ramesh, and S. H. Gan, “Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 1259510, 21 pages, 2017.
- S. Boisard, A. M. Le Ray, J. Gatto et al., “Chemical composition, antioxidant and anti-AGEs activities of a French poplar type propolis,” Journal of Agricultural and Food Chemistry, vol. 62, no. 6, pp. 1344–1351, 2014.
- K. Graikou, M. Popova, O. Gortzi, V. Bankova, and I. Chinou, “Characterization and biological evaluation of selected Mediterranean propolis samples: is it a new type?” LWT—Food Science and Technology, vol. 65, pp. 261–267, 2016.
- V. Bankova, “Chemical diversity of propolis and the problem of standardization,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 114–117, 2005.
- A. Salatino, “Brazilian red propolis: legitimate name of the plant resin source,” MOJ Food Processing & Technology, vol. 6, no. 1, 2018.
- M. L. F. Bittencourt, P. R. Ribeiro, R. L. P. Franco, H. W. M. Hilhorst, R. D. de Castro, and L. G. Fernandez, “Metabolite profiling, antioxidant and antibacterial activities of Brazilian propolis: use of correlation and multivariate analyses to identify potential bioactive compounds,” Food Research International, vol. 76, Part 3, pp. 449–457, 2015.
- A. Daugsch, C. S. Moraes, P. Fort, and Y. K. Park, “Brazilian red propolis—chemical composition and botanical origin,” Evidence-based Complementary and Alternative Medicine, vol. 5, no. 4, 441 pages, 2008.
- P. Ristivojević, J. Trifković, F. Andrić, and D. Milojković-Opsenica, “Poplar-type propolis: chemical composition, botanical origin and biological activity,” Natural Product Communications, vol. 10, no. 11, pp. 1869–1876, 2015.
- S. Narimane, E. Demircan, A. Salah, B. Ö. Ozcelik, and R. Salah, “Correlation between antioxidant activity and phenolic acids profile and content of Algerian propolis: influence of solvent,” Pakistan Journal of Pharmaceutical Sciences, vol. 30, no. 4, pp. 1417–1423, 2017.
- J. K. S. Andrade, M. Denadai, C. S. de Oliveira, M. L. Nunes, and N. Narain, “Evaluation of bioactive compounds potential and antioxidant activity of brown, green and red propolis from Brazilian northeast region,” Food Research International, vol. 101, pp. 129–138, 2017.
- C. Zhang, X. Shen, J. Chen, X. Jiang, and F. Hu, “Identification of free radical scavengers from Brazilian green propolis using off-line HPLC-DPPH assay and LC-MS,” Journal of Food Science, vol. 82, no. 7, pp. 1602–1607, 2017.
- E. Betances-Salcedo, I. Revilla, A. M. Vivar-Quintana, and M. I. González-Martín, “Flavonoid and antioxidant capacity of propolis prediction using near infrared spectroscopy,” Sensors, vol. 17, no. 7, 2017.
- R. Socha, D. Gałkowska, M. Bugaj, and L. Juszczak, “Phenolic composition and antioxidant activity of propolis from various regions of Poland,” Natural Product Research, vol. 29, no. 5, pp. 416–422, 2014.
- S. Fabris, M. Bertelle, O. Astafyeva et al., “Antioxidant properties and chemical composition relationship of European and Brazilian propolis,” Pharmacology & Pharmacy, vol. 4, no. 1, pp. 46–51, 2013.
- M. A. Calegari, A. Prasniewski, C. D. Silva et al., “Propolis from Southwest of Parana produced by selected bees: influence of seasonality and food supplementation on antioxidant activity and phenolic profile,” Anais da Academia Brasileira de Ciências, vol. 89, no. 1, pp. 45–55, 2017.
- T. M. S. Silva, C. A. Camara, A. C. S. Lins et al., “Chemical composition, botanical evaluation and screening of radical scavenging activity of collected pollen by the stingless bees Melipona rufiventris (Uruçu-amarela),” Anais da Academia Brasileira de Ciências, vol. 81, no. 2, pp. 173–178, 2009.
- A. Chantarudee, P. Phuwapraisirisan, K. Kimura et al., “Chemical constituents and free radical scavenging activity of corn pollen collected from Apis mellifera hives compared to floral corn pollen at Nan, Thailand,” BMC Complementary and Alternative Medicine, vol. 12, no. 1, 2012.
- H. Maruyama, T. Sakamoto, Y. Araki, and H. Hara, “Anti-inflammatory effect of bee pollen ethanol extract from Cistus sp. of Spanish on carrageenan-induced rat hind paw edema,” BMC Complementary and Alternative Medicine, vol. 10, no. 1, article 30, 2010.
- V. Mujica, R. Orrego, J. Pérez et al., “The role of propolis in oxidative stress and lipid metabolism: a randomized controlled trial,” Evidence-based Complementary and Alternative Medicine, vol. 2017, Article ID 4272940, 11 pages, 2017.
- I. Jasprica, A. Mornar, Z. Debeljak et al., “In vivo study of propolis supplementation effects on antioxidative status and red blood cells,” Journal of Ethnopharmacology, vol. 110, no. 3, pp. 548–554, 2007.
- L. Zhao, L. Pu, J. Wei et al., “Brazilian green propolis improves antioxidant function in patients with type 2 diabetes mellitus,” International Journal of Environmental Research and Public Health, vol. 13, no. 5, 2016.
- J. Ni, Z. Wu, J. Meng et al., “The neuroprotective effects of Brazilian green propolis on neurodegenerative damage in human neuronal SH-SY5Y Cells,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 7984327, 13 pages, 2017.
- S. Nanaware, M. Shelar, A. Sinnathambi, K. R. Mahadik, and S. Lohidasan, “Neuroprotective effect of Indian propolis in β-amyloid induced memory deficit: impact on behavioral and biochemical parameters in rats,” Biomedicine & Pharmacotherapy, vol. 93, pp. 543–553, 2017.
- M. R. de Oliveira, A. Peres, C. S. Gama, and S. M. D. Bosco, “Pinocembrin provides mitochondrial protection by the activation of the Erk1/2-Nrf2 signaling pathway in SH-SY5Y neuroblastoma cells exposed to paraquat,” Molecular Neurobiology, vol. 54, no. 8, pp. 6018–6031, 2017.
- A. M. Mahmoud and S. M. Abd El-Twab, “Caffeic acid phenethyl ester protects the brain against hexavalent chromium toxicity by enhancing endogenous antioxidants and modulating the JAK/STAT signaling pathway,” Biomedicine & Pharmacotherapy, vol. 91, pp. 303–311, 2017.
- S. Kumari, G. Nayak, S. T. Lukose et al., “Indian propolis ameliorates the mitomycin C-induced testicular toxicity by reducing DNA damage and elevating the antioxidant activity,” Biomedicine & Pharmacotherapy, vol. 95, pp. 252–263, 2017.
- R. E. Salmas, M. F. Gulhan, S. Durdagi, E. Sahna, H. I. Abdullah, and Z. Selamoglu, “Effects of propolis, caffeic acid phenethyl ester, and pollen on renal injury in hypertensive rat: an experimental and theoretical approach,” Cell Biochemistry and Function, vol. 35, no. 6, pp. 304–314, 2017.
- R. Ahmed, E. M. Tanvir, M. D. Sakib Hossen et al., “Antioxidant properties and cardioprotective mechanism of Malaysian propolis in rats,” Evidence-based Complementary and Alternative Medicine, vol. 2017, Article ID 5370545, 11 pages, 2017.
- L. Sun, K. Wang, X. Xu, M. Ge, Y. Chen, and F. Hu, “Potential protective effects of bioactive constituents from Chinese propolis against acute oxidative stress induced by hydrogen peroxide in cardiac H9c2 cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 7074147, 10 pages, 2017.
- Y. Fang, J. Li, M. Ding et al., “Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress,” Experimental Biology and Medicine, vol. 239, no. 12, pp. 1678–1687, 2014.
- T. Sawamura, N. Kume, T. Aoyama et al., “An endothelial receptor for oxidized low-density lipoprotein,” Nature, vol. 386, no. 6620, pp. 73–77, 1997.
- H. Tian, H. W. Sun, J. J. Zhang et al., “Ethanol extract of propolis protects macrophages from oxidized low density lipoprotein-induced apoptosis by inhibiting CD36 expression and endoplasmic reticulum stress-C/EBP homologous protein pathway,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article 230, 2015.
- M. S. El-Awady, D. S. El-Agamy, G. M. Suddek, and M. A. Nader, “Propolis protects against high glucose-induced vascular endothelial dysfunction in isolated rat aorta,” Journal of Physiology and Biochemistry, vol. 70, no. 1, pp. 247–254, 2014.
- M. E. Yonar, S. M. Yonar, A. Pala, S. Silici, and N. Sağlam, “Trichlorfon-induced haematological and biochemical changes in Cyprinus carpio: ameliorative effect of propolis,” Diseases of Aquatic Organisms, vol. 114, no. 3, pp. 209–216, 2015.
- E. H. Aksu, M. Özkaraca, F. M. Kandemir et al., “Mitigation of paracetamol-induced reproductive damage by chrysin in male rats via reducing oxidative stress,” Andrologia, vol. 48, no. 10, pp. 1145–1154, 2016.
- E. S. Manzolli, J. M. Serpeloni, D. Grotto et al., “Protective effects of the flavonoid chrysin against methylmercury-induced genotoxicity and alterations of antioxidant status, in vivo,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 602360, 7 pages, 2015.
- Y. Saito, K. Tsuruma, K. Ichihara, M. Shimazawa, and H. Hara, “Brazilian green propolis water extract up-regulates the early expression level of HO-1 and accelerates Nrf2 after UVA irradiation,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, p. 421, 2015.
- X. P. Cao, Y. F. Chen, J. L. Zhang, M. M. You, K. Wang, and F. L. Hu, “Mechanisms underlying the wound healing potential of propolis based on its in vitro antioxidant activity,” Phytomedicine, vol. 34, pp. 76–84, 2017.
- A. Arabameri, H. Sameni, and A. Bandegi, “The effects of propolis extract on ovarian tissue and oxidative stress in rats with maternal separation stress,” International Journal of Reproductive BioMedicine, vol. 15, no. 8, pp. 509–520, 2017.
- S. Mişe Yonar, K. Köprücü, M. E. Yonar, and S. Silici, “Effects of dietary propolis on the number and size of pleopadal egg, oxidative stress and antioxidant status of freshwater crayfish (Astacus leptodactylus Eschscholtz),” Animal Reproduction Science, vol. 184, pp. 149–159, 2017.
- J. Zhang, X. Cao, S. Ping et al., “Comparisons of ethanol extracts of Chinese propolis (poplar type) and poplar gums based on the antioxidant activities and molecular mechanism,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 307594, 15 pages, 2015.
- J. Lu and A. Holmgren, “The thioredoxin antioxidant system,” Free Radical Biology and Medicine, vol. 66, pp. 75–87, 2014.
- C. Couteau, M. Pommier, E. Paparis, and L. J. M. Coiffard, “Photoprotective activity of propolis,” Natural Product Research, vol. 22, no. 3, pp. 264–268, 2008.
- E. Gregoris, S. Fabris, M. Bertelle, L. Grassato, and R. Stevanato, “Propolis as potential cosmeceutical sunscreen agent for its combined photoprotective and antioxidant properties,” International Journal of Pharmaceutics, vol. 405, no. 1-2, pp. 97–101, 2011.
- A. Gismondi, L. Canuti, M. Grispo, and A. Canini, “Biochemical composition and antioxidant properties of Lavandula angustifolia Miller essential oil are shielded by propolis against UV radiations,” Photochemistry and Photobiology, vol. 90, no. 3, pp. 702–708, 2014.
- G. Negri, E. W. Teixeira, M. L. Alves et al., “Hydroxycinnamic acid amide derivatives, phenolic compounds and antioxidant activities of extracts of pollen samples from Southeast Brazil,” Journal of Agricultural and Food Chemistry, vol. 59, no. 10, pp. 5516–5522, 2011.
- K. Komosinska-Vassev, P. Olczyk, J. Kaźmierczak, L. Mencner, and K. Olczyk, “Bee pollen: chemical composition and therapeutic application,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 297425, 6 pages, 2015.
- M. Krystyjan, D. Gumul, R. Ziobro, and A. Korus, “The fortification of biscuits with bee pollen and its effect on physicochemical and antioxidant properties in biscuits,” LWT—Food Science and Technology, vol. 63, no. 1, pp. 640–646, 2015.
- A. A. A. Mohdaly, A. A. Mahmoud, M. H. H. Roby, I. Smetanska, and M. F. Ramadan, “Phenolic extract from propolis and bee pollen: composition, antioxidant and antibacterial activities,” Journal of Food Biochemistry, vol. 39, no. 5, pp. 538–547, 2015.
- X. Feás, M. P. Vázquez-Tato, L. Estevinho, J. A. Seijas, and A. Iglesias, “Organic bee pollen: botanical origin, nutritional value, bioactive compounds, antioxidant activity and microbiological quality,” Molecules, vol. 17, no. 7, pp. 8359–8377, 2012.
- A. Pascoal, S. Rodrigues, A. Teixeira, X. Feás, and L. M. Estevinho, “Biological activities of commercial bee pollens: antimicrobial, antimutagenic, antioxidant and anti-inflammatory,” Food and Chemical Toxicology, vol. 63, pp. 233–239, 2014.
- K. Graikou, S. Kapeta, N. Aligiannis et al., “Chemical analysis of Greek pollen—antioxidant, antimicrobial and proteasome activation properties,” Chemistry Central Journal, vol. 5, no. 1, article 33, 2011.
- A. Šarić, T. Balog, S. Sobocanec et al., “Antioxidant effects of flavonoid from Croatian Cystus incanus L. rich bee pollen,” Food and Chemical Toxicology, vol. 47, no. 3, pp. 547–554, 2009.
- Z. Kalaycıoğlu, H. Kaygusuz, S. Döker, S. Kolaylı, and F. B. Erim, “Characterization of Turkish honeybee pollens by principal component analysis based on their individual organic acids, sugars, minerals, and antioxidant activities,” LWT—Food Science and Technology, vol. 84, pp. 402–408, 2017.
- R. Mărgăoan, L. A. Mărghitaş, D. S. Dezmirean et al., “Predominant and secondary pollen botanical origins influence the carotenoid and fatty acid profile in fresh honeybee-collected pollen,” Journal of Agricultural and Food Chemistry, vol. 62, no. 27, pp. 6306–6316, 2014.
- K. R. L. Freire, A. C. S. Lins, M. C. Dórea, F. A. R. Santos, C. A. Camara, and T. M. S. Silva, “Palynological origin, phenolic content, and antioxidant properties of honeybee-collected pollen from Bahia, Brazil,” Molecules, vol. 17, no. 2, pp. 1652–1664, 2012.
- J. S. Araújo, E. D. Chambó, M. A. P. C. Costa, S. M. P. Cavalcante da Silva, C. A. Lopes de Carvalho, and L. M Estevinho, “Chemical composition and biological activities of mono- and heterofloral bee pollen of different geographical origins,” International Journal of Molecular Sciences, vol. 18, no. 5, 2017.
- Y. Zhang, F. Yang, M. A. Jamali, and Z. Peng, “Antioxidant enzyme activities and lipid oxidation in rape (Brassica campestris L.) bee pollen added to salami during processing,” Molecules, vol. 21, no. 11, p. 1439, 2016.
- M. G. Campos, R. F. Webby, K. R. Markham, K. A. Mitchell, and A. P. da Cunha, “Age-induced diminution of free radical scavenging capacity in bee pollens and the contribution of constituent flavonoids,” Journal of Agricultural and Food Chemistry, vol. 51, no. 3, pp. 742–745, 2003.
- C. Sousa, E. Moita, P. Valentão, F. Fernandes, P. Monteiro, and P. B. Andrade, “Effects of colored and noncolored phenolics of Echium plantagineum L. bee pollen in Caco-2 cells under oxidative stress induced bytert-butyl hydroperoxide,” Journal of Agricultural and Food Chemistry, vol. 63, no. 7, pp. 2083–2091, 2015.
- L. Sun, Y. Guo, Y. Zhang, and Y. Zhuang, “Antioxidant and anti-tyrosinase activities of phenolic extracts from rape bee pollen and inhibitory melanogenesis by cAMP/MITF/TYR pathway in B16 mouse melanoma cells,” Frontiers in Pharmacology, vol. 8, 2017.
- M. Leja, A. Mareczek, G. Wyżgolik, J. Klepacz-Baniak, and K. Czekońska, “Antioxidative properties of bee pollen in selected plant species,” Food Chemistry, vol. 100, no. 1, pp. 237–240, 2007.
- H. Huang, Z. Shen, Q. Geng, Z. Wu, P. Shi, and X. Miao, “Protective effect of Schisandra chinensis bee pollen extract on liver and kidney injury induced by cisplatin in rats,” Biomedicine & Pharmacotherapy, vol. 95, pp. 1765–1776, 2017.
- A. A. Tohamy, E. M. Abdella, R. R. Ahmed, and Y. K. Ahmed, “Assessment of anti-mutagenic, anti-histopathologic and antioxidant capacities of Egyptian bee pollen and propolis extracts,” Cytotechnology, vol. 66, no. 2, pp. 283–297, 2014.
- W. A. W. Omar, N. A. Azhar, N. H. Fadzilah, and N. N. S. N. M. Kamal, “Bee pollen extract of Malaysian stingless bee enhances the effect of cisplatin on breast cancer cell lines,” Asian Pacific Journal of Tropical Biomedicine, vol. 6, no. 3, pp. 265–269, 2016.
- B. E. El-Bialy, E. E. Abdeen, N. B. El-Borai, and E. M. El-Diasty, “Experimental studies on some immunotoxicological aspects of aflatoxins containing diet and protective effect of bee pollen dietary supplement,” Pakistan Journal of Biological Sciences, vol. 19, no. 1, pp. 26–35, 2016.
- S. Ketkar, A. Rathore, A. Kandhare et al., “Alleviating exercise-induced muscular stress using neat and processed bee pollen: oxidative markers, mitochondrial enzymes, and myostatin expression in rats,” Integrative Medicine Research, vol. 4, no. 3, pp. 147–160, 2015.
- N. Almaraz-Abarca, M. da Graça Campos, J. A. Ávila-Reyes, N. Naranjo-Jiménez, J. H. Corral, and L. S. González-Valdez, “Antioxidant activity of polyphenolic extract of monofloral honeybee-collected pollen from mesquite (Prosopis juliflora, Leguminosae),” Journal of Food Composition and Analysis, vol. 20, no. 2, pp. 119–124, 2007.
- V. A. Isidorov, S. Bakier, and I. Grzech, “Gas chromatographic-mass spectrometric investigation of volatile and extractable compounds of crude royal jelly,” Journal of Chromatography B, vol. 885-886, pp. 109–116, 2012.
- E. Melliou and I. Chinou, “Chemistry and bioactivities of royal jelly,” in W: Atta-ur-Rahman: Studies in Natural Products Chemistry, pp. 261–290, Elsevier, 2017.
- Y. Wang, L. Ma, W. Zhang, X. Cui, H. Wang, and B. Xu, “Comparison of the nutrient composition of royal jelly and worker jelly of honey bees (Apis mellifera),” Apidologie, vol. 47, no. 1, pp. 48–56, 2016.
- A. Chittka and L. Chittka, “Epigenetics of royalty,” PLoS Biology, vol. 8, no. 11, article e1000532, 2010.
- F. Fratini, G. Cilia, S. Mancini, and A. Felicioli, “Royal jelly: an ancient remedy with remarkable antibacterial properties,” Microbiological Research, vol. 192, pp. 130–141, 2016.
- D. Kanelis, C. Tananaki, V. Liolios et al., “A suggestion for royal jelly specifications,” Archives of Industrial Hygiene and Toxicology, vol. 66, no. 4, pp. 275–284, 2015.
- S. Silici, O. Ekmekcioglu, G. Eraslan, and A. Demirtas, “Antioxidative effect of royal jelly in cisplatin-induced testes damage,” Urology, vol. 74, no. 3, pp. 545–551, 2009.
- M. Kamakura, T. Fukuda, M. Fukushima, and M. Yonekura, “Storage-dependent degradation of 57-kDa protein in royal jelly: a possible marker for freshness,” Bioscience, Biotechnology, and Biochemistry, vol. 65, no. 2, pp. 277–284, 2014.
- N. López-Gutiérrez, M. del Mar Aguilera-Luiz, R. Romero-González, J. L. M. Vidal, and A. G. Frenich, “Fast analysis of polyphenols in royal jelly products using automated TurboFlow™-liquid chromatography-Orbitrap high resolution mass spectrometry,” Journal of Chromatography B, vol. 973, pp. 17–28, 2014.
- L. H. Garcia-Amoedo and L. B. de Almeida-Muradian, “Physicochemical composition of pure and adulterated royal jelly,” Química Nova, vol. 30, no. 2, 2007.
- Z. Nabas, M. S. Y. Haddadin, J. Haddadin, and I. K. Nazer, “Chemical composition of royal jelly and effects of synbiotic with two different locally isolated probiotic strains on antioxidant activities,” Polish Journal of Food and Nutrition Sciences, vol. 64, no. 3, 2014.
- N. Oršolić, “Royal jelly: component efficiency, analysis, and standardisation,” Arhiv za Higijenu Rada i Toksikologiju, vol. 64, no. 3, pp. 445–461, 2013.
- M. Wytrychowski, G. Daniele, and H. Casabianca, “Combination of sugar analysis and stable isotope ratio mass spectrometry to detect the use of artificial sugars in royal jelly production,” Analytical and Bioanalytical Chemistry, vol. 403, no. 5, pp. 1451–1456, 2012.
- T. Takenaka and Y. Takenaka, “Royal jelly from Apis cerana japonica and Apis mellifera,” Bioscience, Biotechnology, and Biochemistry, vol. 60, no. 3, pp. 518–520, 2014.
- S. C. Mandacaru, L. H. F. do Vale, S. Vahidi et al., “Characterizing the structure and oligomerization of major royal jelly protein 1 (MRJP1) by mass spectrometry and complementary biophysical tools,” Biochemistry, vol. 56, no. 11, pp. 1645–1655, 2017.
- M. Kamakura, “Royalactin induces queen differentiation in honeybees,” Nature, vol. 473, no. 7348, pp. 478–483, 2011.
- J. R. Liu, Y. C. Yang, L. S. Shi, and C. C. Peng, “Antioxidant properties of royal jelly associated with larval age and time of harvest,” Journal of Agricultural and Food Chemistry, vol. 56, no. 23, pp. 11447–11452, 2008.
- M. Kanbur, G. Eraslan, S. Silici, and M. Karabacak, “Effects of sodium fluoride exposure on some biochemical parameters in mice: evaluation of the ameliorative effect of royal jelly applications on these parameters,” Food and Chemical Toxicology, vol. 47, no. 6, pp. 1184–1189, 2009.
- H. Guo, Y. Kouzuma, and M. Yonekura, “Structures and properties of antioxidative peptides derived from royal jelly protein,” Food Chemistry, vol. 113, no. 1, pp. 238–245, 2009.
- S. Watanabe, K. Suemaru, K. Takechi, H. Kaji, K. Imai, and H. Araki, “Oral mucosal adhesive films containing royal jelly accelerate recovery from 5-fluorouracil-induced oral mucositis,” Journal of Pharmacological Sciences, vol. 121, no. 2, pp. 110–118, 2013.
- S. Pourmoradian, R. Mahdavi, M. Mobasseri, E. Faramarzi, and M. Mobasseri, “Effects of royal jelly supplementation on glycemic control and oxidative stress factors in type 2 diabetic female: a randomized clinical trial,” Chinese Journal of Integrative Medicine, vol. 20, no. 5, pp. 347–352, 2014.
- F. Shidfar, S. Jazayeri, S. N. Mousavi, M. Malek, A. F. Hosseini, and B. Khoshpey, “Does supplementation with royal jelly improve oxidative stress and insulin resistance in type 2 diabetic patients?” Iranian Journal of Public Health, vol. 44, no. 6, pp. 797–803, 2015.
- E. Ghanbari, V. Nejati, and M. Khazaei, “Improvement in serum biochemical alterations and oxidative stress of liver and pancreas following use of royal jelly in streptozotocin-induced diabetic rats,” Cell Journal, vol. 18, no. 3, pp. 362–370, 2016.
- E. Ghanbari, V. Nejati, and M. Khazaei, “Antioxidant and protective effects of royal jelly on histopathological changes in testis of diabetic rats,” International Journal of Reproductive BioMedicine, vol. 14, no. 8, pp. 519–526, 2016.
- A. A. Mohamed, A. A. Galal, and Y. H. Elewa, “Comparative protective effects of royal jelly and cod liver oil against neurotoxic impact of tartrazine on male rat pups brain,” Acta Histochemica, vol. 117, no. 7, pp. 649–658, 2015.
- A. Aslan, M. Cemek, M. E. Buyukokuroglu, K. Altunbas, O. Bas, and Y. Yurumez, “Royal jelly can diminish secondary neuronal damage after experimental spinal cord injury in rabbits,” Food and Chemical Toxicology, vol. 50, no. 7, pp. 2554–2559, 2012.
- R. R. Teixeira, A. V. de Souza, L. G. Peixoto et al., “Royal jelly decreases corticosterone levels and improves the brain antioxidant system in restraint and cold stressed rats,” Neuroscience Letters, vol. 655, pp. 179–185, 2017.
- S. Silici, O. Ekmekcioglu, M. Kanbur, and K. Deniz, “The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats,” World Journal of Urology, vol. 29, no. 1, pp. 127–132, 2011.
- Y. Nakajima, K. Tsuruma, M. Shimazawa, S. Mishima, and H. Hara, “Comparison of bee products based on assays of antioxidant capacities,” BMC Complementary and Alternative Medicine, vol. 9, no. 1, article 4, 2009.
- M. Cemek, F. Aymelek, M. E. Büyükokuroğlu, T. Karaca, A. Büyükben, and F. Yilmaz, “Protective potential of Royal Jelly against carbon tetrachloride induced-toxicity and changes in the serum sialic acid levels,” Food and Chemical Toxicology, vol. 48, no. 10, pp. 2827–2832, 2010.
- W. M. Ahmed, A. A. Khalaf, W. A. Moselhy, and G. M. Safwat, “Royal jelly attenuates azathioprine induced toxicity in rats,” Environmental Toxicology and Pharmacology, vol. 37, no. 1, pp. 431–437, 2014.
- T. Amirshahi, G. Najafi, and V. Nejati, “Protective effect of royal jelly on fertility and biochemical parameters in bleomycin-induced male rats,” International Journal of Reproductive BioMedicine, vol. 12, no. 3, pp. 209–216, 2014.
- L. Kaynar, A. Cetin, S. K. Hacioglu et al., “Efficacy of royal jelly on methotrexate-induced systemic oxidative stress and damage to small intestine in rats,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 9, no. 3, pp. 412–417, 2012.
- H. Malekinejad, S. Ahsan, F. Delkhosh-Kasmaie, H. Cheraghi, A. Rezaei-Golmisheh, and H. Janbaz-Acyabar, “Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats,” Iranian Journal of Basic Medical Sciences, vol. 19, no. 2, pp. 221–227, 2016.
- F. Delkhoshe-Kasmaie, H. Malekinejad, M. Khoramjouy, A. Rezaei-Golmisheh, and H. Janbaze-Acyabar, “Royal jelly protects from taxol-induced testicular damages via improvement of antioxidant status and up-regulation of E2f1,” Systems Biology in Reproductive Medicine, vol. 60, no. 2, pp. 80–88, 2014.
- V. Nejati, E. Zahmatkesh, and M. Babaei, “Protective effects of royal jelly on oxymetholone-induced liver injury in mice,” Iranian Biomedical Journal, vol. 20, no. 4, pp. 229–234, 2016.
- L. P. Manzo, F. M. de-Faria, R. J. Dunder et al., “Royal jelly and its dual role in TNBS colitis in mice,” The Scientific World Journal, vol. 2015, Article ID 956235, 7 pages, 2015.
- Y. Inoue, H. Hara, Y. Mitsugi et al., “4-Hydroperoxy-2-decenoic acid ethyl ester protects against 6-hydroxydopamine-induced cell death via activation of Nrf2-ARE and eIF2α-ATF4 pathways,” Neurochemistry International, vol. 112, pp. 288–296, 2018.
- M. Eshtiyaghi, H. Deldar, Z. A. Pirsaraei, and B. Shohreh, “Royal jelly may improve the metabolism of glucose and redox state of ovine oocytes matured in vitro and embryonic development following in vitro fertilization,” Theriogenology, vol. 86, no. 9, pp. 2210–2221, 2016.
- B. Filipič, L. Gradišnik, K. Rihar, E. Šooš, A. Pereyra, and J. Potokar, “The influence of royal jelly and human interferon-alpha (HuIFN-αN3) on proliferation, glutathione level and lipid peroxidation in human colorectal adenocarcinoma cells in vitro,” Arhiv za Higijenu Rada i Toksikologiju, vol. 66, no. 4, pp. 269–274, 2015.
- T. Sugiyama, K. Takahashi, A. Kuzumaki, S. Tokoro, P. Neri, and H. Mori, “Inhibitory mechanism of 10-hydroxy-trans-2-decenoic acid (royal jelly acid) against lipopolysaccharide- and interferon-β-induced nitric oxide production,” Inflammation, vol. 36, no. 2, pp. 372–378, 2013.
- K. Takahashi, T. Sugiyama, S. Tokoro, P. Neri, and H. Mori, “Inhibition of interferon-γ-induced nitric oxide production by 10-hydroxy-trans-2-decenoic acid through inhibition of interferon regulatory factor-8 induction,” Cellular Immunology, vol. 273, no. 1, pp. 73–78, 2012.
- M. Morais, L. Moreira, X. Feás, and L. M. Estevinho, “Honeybee-collected pollen from five Portuguese Natural Parks: palynological origin, phenolic content, antioxidant properties and antimicrobial activity,” Food and Chemical Toxicology, vol. 49, no. 5, pp. 1096–1101, 2011.
- Ö. Saral, O. Yildiz, R. Aliyazicioğlu et al., “Apitherapy products enhance the recovery of CCL4-induced hepatic damages in rats,” Turkish Journal of Medical Sciences, vol. 46, no. 1, pp. 194–202, 2016.
- E. Moita, A. Gil-Izquierdo, C. Sousa et al., “Integrated analysis of COX-2 and iNOS derived inflammatory mediators in LPS-stimulated RAW macrophages pre-exposed to Echium plantagineum L. bee pollen extract,” PLoS One, vol. 8, no. 3, article e59131, 2013.
- A. N. Croci, B. Cioroiu, D. Lazar, A. N. Corciova, B. Ivanescu, and M. I. Lazar, “HPLC evaluation of phenolic and polyphenolic acids from propolis,” Farmacia, vol. 58, pp. 52–57, 2009.
Copyright © 2018 Joanna Kocot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.